29868-97-1 | Pirenzepine HCl

Packsize	Purity	Availability	Price	Discounted Price
25mg	99+%	in stock	$6.00	$4.00
100mg	99+%	in stock	$15.00	$11.00
250mg	99+%	in stock	$21.00	$15.00
1g	99+%	in stock	$42.00	$30.00
5g	99+%	in stock	$167.00	$117.00

Description

• Catalog Number: AD52445
• Chemical Name: Pirenzepine HCl
• CAS Number: 29868-97-1
• Molecular Formula: C19H23Cl2N5O2
• Molecular Weight: 424.3242
• MDL Number: MFCD07364040
• SMILES: CN1CCN(CC1)CC(=O)n1c2ccccc2c(=O)[nH]c2c1nccc2.Cl.Cl

Computed Properties

• Complexity: 534
• Covalently-Bonded Unit Count: 3
• Heavy Atom Count: 28
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 2

Literature

• Modulating rheological and degradation properties of temperature-responsive gelling systems composed of blends of PCLA-PEG-PCLA triblock copolymers and their fully hexanoyl-capped derivatives.

  Acta biomaterialia 20121201

• Muscarinic acetylcholine receptor-mediated effects in slices from human epileptogenic cortex.

  Neuroscience 20121025

• Muscarinic receptor subtypes involved in urothelium-derived relaxatory effects in the inflamed rat urinary bladder.

  Autonomic neuroscience : basic & clinical 20120925

• Near-complete adaptation of the PRiMA knockout to the lack of central acetylcholinesterase.

  Journal of neurochemistry 20120901

• Acute desensitization of acetylcholine and endothelin-1 activated inward rectifier K+ current in myocytes from the cardiac atrioventricular node.

  Biochemical and biophysical research communications 20120706

• Differential effects of m1 and m2 receptor antagonists in perirhinal cortex on visual recognition memory in monkeys.

  Neurobiology of learning and memory 20120701

• Activation of muscarinic receptors increases the activity of the granule neurones of the rat dorsal cochlear nucleus--a calcium imaging study.

  Pflugers Archiv : European journal of physiology 20120601

• Calcium-dependent but action potential-independent BCM-like metaplasticity in the hippocampus.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20120516

• Functional role of muscarinic receptor subtypes in calcium sensitization and their contribution to rho-kinase and protein kinase C pathways in contraction of human detrusor smooth muscle.

  Urology 20120501

• Functional M3 cholinoreceptors are present in pacemaker and working myocardium of murine heart.

  Pflugers Archiv : European journal of physiology 20120401

• Interindividual variation in olanzapine concentration influenced by UGT1A4 L48V polymorphism in serum and upstream FMO polymorphisms in cerebrospinal fluid.

  Journal of clinical psychopharmacology 20120401

• Muscarinic receptor/G-protein coupling is reduced in the dorsomedial striatum of cognitively impaired aged rats.

  Behavioural brain research 20120201

• Expanding the multipotent profile of huprine-tacrine heterodimers as disease-modifying anti-Alzheimer agents.

  Neuro-degenerative diseases 20120101

• [Acetylcholine induces human detrusor muscle cell proliferation: molecular and pharmacological characterization].

  Urologia 20120101

• Role of various subtypes of muscarinic cholinergic receptors in the development of posthemorrhagic abnormalities in systemic and portal circulation in rats.

  Bulletin of experimental biology and medicine 20120101

• Characterization of a new muscarinic toxin from the venom of the Brazilian coral snake Micrurus lemniscatus in rat hippocampus.

  Life sciences 20111219

• Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol.

  Urology 20111201

• Muscarinic receptor subtypes involved in regulation of colonic motility in mice: functional studies using muscarinic receptor-deficient mice.

  European journal of pharmacology 20111116

• M3-receptor activation counteracts opioid-mediated apneusis, but the apneusis per se is not necessarily related to an impaired M3 mechanism in rats.

  Life sciences 20111107

• Role of M1 receptor in regulation of gastric fundus smooth muscle contraction.

  Postepy higieny i medycyny doswiadczalnej (Online) 20110914

• The metabolites N-desmethylclozapine and N-desmethylolanzapine produce cross-tolerance to the discriminative stimulus of the atypical antipsychotic clozapine in C57BL/6 mice.

  Behavioural pharmacology 20110901

• Intracellular distribution of functional M(1) -muscarinic acetylcholine receptors in N1E-115 neuroblastoma cells.

  Journal of neurochemistry 20110901

• Modulating activity of M1 receptor to the reaction of ileal smooth muscle.

  Postepy higieny i medycyny doswiadczalnej (Online) 20110803

• BK channel β1 subunits regulate airway contraction secondary to M2 muscarinic acetylcholine receptor mediated depolarization.

  The Journal of physiology 20110401

• The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapine.

  British journal of clinical pharmacology 20110401

• An evidence-based update on myopia and interventions to retard its progression.

  Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20110401

• Involvement of decreased muscarinic receptor function in prepulse inhibition deficits in mice reared in social isolation.

  British journal of pharmacology 20110201

• Investigation of gastrin-releasing peptide as a mediator for 5'-guanidinonaltrindole-induced compulsive scratching in mice.

  Peptides 20110201

• Role of curcumin in the prevention of cholinergic mediated cortical dysfunctions in streptozotocin-induced diabetic rats.

  Molecular and cellular endocrinology 20110101

• Colonic inflammation increases the contribution of muscarinic M2 receptors to carbachol-induced contraction of the rat colon.

  Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20110101

• Modulation of peripheral inflammatory pain thresholds by M(1) and nicotinic receptor antagonists.

  Pharmacology 20110101

• Interventions to slow progression of myopia in children.

  The Cochrane database of systematic reviews 20110101

• The interaction between tropomyosin-related kinase B receptors and presynaptic muscarinic receptors modulates transmitter release in adult rodent motor nerve terminals.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20101208

• Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability.

  The Journal of pharmacology and experimental therapeutics 20101201

• Liquid chromatography/tandem mass spectrometry method for determination of olanzapine and N-desmethylolanzapine in human serum and cerebrospinal fluid.

  Journal of pharmaceutical and biomedical analysis 20101102

• The effect of pirenzepine on positive- and negative-lens-induced refractive error and ocular growth in chicks.

  Investigative ophthalmology & visual science 20101101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Loss of muscarinic and purinergic receptors in urinary bladder of rats with hydrochloric acid-induced cystitis.

  Urology 20101001

• M₃muscarinic receptors mediate acetylcholine-induced pulmonary vasodilation in pulmonary hypertension.

  Bioscience trends 20101001

• Effects of benzodiazepine treatment on cortical GABA(A) and muscarinic receptors: studies in schizophrenia and rats.

  Psychiatry research 20100930

• Muscarinic receptor type 1 (M1) stimulation, probably through KCNQ/Kv7 channel closure, increases spontaneous GABA release at the dendrodendritic synapse in the mouse accessory olfactory bulb.

  Brain research 20100621

• A fluorescence anisotropy assay for the muscarinic M1 G-protein-coupled receptor.

  Assay and drug development technologies 20100601

• Detection of novel functional selectivity at M3 muscarinic acetylcholine receptors using a Saccharomyces cerevisiae platform.

  ACS chemical biology 20100416

• Cholinergic autoantibodies from primary Sjögren's syndrome modulate submandibular gland Na+/K+-ATPase activity via prostaglandin E2 and cyclic AMP.

  European journal of oral sciences 20100401

• Decreased kainate receptors in the hippocampus of apolipoprotein D knockout mice.

  Progress in neuro-psychopharmacology & biological psychiatry 20100317

• [Effect on of pirenzepine on expression of mAChRs in the ocular tissues of guinea pig with form-deprived myopia].

  [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20100301

• Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules.

  Proceedings of the National Academy of Sciences of the United States of America 20100209

• Role of surface free energy and spreading coefficient in the formulation of active agent-layered pellets.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20100201

• Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia.

  Molecular psychiatry 20091101

• Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex.

  The Journal of pharmacology and experimental therapeutics 20090901

• Negative crosstalk between M1 and M2 muscarinic autoreceptors involves endogenous adenosine activating A1 receptors at the rat motor endplate.

  Neuroscience letters 20090814

• Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090801

• Pirenzepine promotes the dimerization of muscarinic M1 receptors through a three-step binding process.

  The Journal of biological chemistry 20090717

• Spinal cholinergic mechanism of the relieving effects of electroacupuncture on cold and warm allodynia in a rat model of neuropathic pain.

  The journal of physiological sciences : JPS 20090701

• A cholinergic-dependent role for the entorhinal cortex in trace fear conditioning.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20090624

• Treatment options for myopia.

  Optometry and vision science : official publication of the American Academy of Optometry 20090601

• An increase in intracelluar free calcium ions modulated by cholinergic receptors in rat facial nucleus.

  Chinese medical journal 20090505

• Presynaptic muscarinic receptors enhance glutamate release at the mitral/tufted to granule cell dendrodendritic synapse in the rat main olfactory bulb.

  Journal of neurophysiology 20090401

• Functional characterization of the muscarinic receptors involved in endothelium-dependent relaxation in isolated canine uterine artery.

  Journal of veterinary pharmacology and therapeutics 20090401

• Inhibition of transmitter release from rat sympathetic neurons via presynaptic M(1) muscarinic acetylcholine receptors.

  British journal of pharmacology 20090401

• [Mechanism of Smad 3 signaling pathway and connective tissue growth factor in the inhibition of form deprivation myopia by pirenzepine].

  Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20090401

• Regional changes in the cholinergic system in mice lacking monoamine oxidase A.

  Brain research bulletin 20090330

• Nucleus accumbens acetylcholine and food intake: decreased muscarinic tone reduces feeding but not food-seeking.

  Behavioural brain research 20090302

• [Refractive errors].

  La Revue du praticien 20090220

• Perinatal PCP treatment alters the developmental expression of prefrontal and hippocampal muscarinic receptors.

  Progress in neuro-psychopharmacology & biological psychiatry 20090201

• Muscarinic cholinergic modulation of synaptic transmission and plasticity in rat hippocampus following chronic lead exposure.

  Naunyn-Schmiedeberg's archives of pharmacology 20090101

• Acetylcholine activity in selective striatal regions supports behavioral flexibility.

  Neurobiology of learning and memory 20090101

• Secretion from acinar cells of the exocrine pancreas: role of enteropancreatic reflexes and cholecystokinin.

  Cell biology international 20090101

• Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice.

  British journal of pharmacology 20090101

• [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].

  Khirurgiia 20090101

• Presynaptic M1, M2, and A1 receptors play roles in tetanic fade induced by pancuronium or cisatracurium.

  Journal of anesthesia 20090101

• Identification of M(1) muscarinic receptor subtype in rat stomach using a tissue segment binding method, and the effects of immobilization stress on the muscarinic receptors.

  European journal of pharmacology 20081203

• Levels of [(3)H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1.

  Schizophrenia research 20081201

• Central muscarinic receptor subtypes involved in pilocarpine-induced salivation, hypertension and water intake.

  British journal of pharmacology 20081201

• Decreased M1 muscarinic receptor density in rat amphetamine model of schizophrenia is normalized by clozapine, but not haloperidol.

  Journal of neural transmission (Vienna, Austria : 1996) 20081101

• Effect of muscarinic receptor agonists xanomeline and sabcomeline on acetylcholine and dopamine efflux in the rat brain; comparison with effects of 4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one (AC260584) and N-desmethylclozapine.

  European journal of pharmacology 20081031

• Development of a homogeneous high-throughput live-cell G-protein-coupled receptor binding assay.

  Journal of biomolecular screening 20080901

• Cholinergic modulation of hippocampal CA1 basal-dendritic long-term potentiation.

  Neurobiology of learning and memory 20080901

• Role of muscarinic receptors in the activity of N-desmethylclozapine: reversal of hyperactivity in the phospholipase C knockout mouse.

  Behavioural pharmacology 20080901

• Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia.

  Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20080801

• Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.

  Bioorganic & medicinal chemistry 20080801

• Asymmetrical distributions of muscarinic receptor binding in the hippocampus of female rats.

  European journal of pharmacology 20080707

• Chronic treatment with simvastatin upregulates muscarinic M1/4 receptor binding in the rat brain.

  Neuroscience 20080626

• Muscarinic receptors involved in airway vascular leakage induced by experimental gastro-oesophageal reflux.

  Life sciences 20080423

• Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism.

  European journal of pharmacology 20080317

• The effects of mercury on muscarinic cholinergic receptor subtypes (M1 and M2) in captive mink.

  Neurotoxicology 20080301

• [Adjunctive therapies to glycaemic control of type 1 diabetes mellitus].

  Arquivos brasileiros de endocrinologia e metabologia 20080301

• Subtype-selective blockade of cardiac muscarinic receptors inhibits vagal chronotropic responses in cats.

  Pflugers Archiv : European journal of physiology 20080201

• Changes in muscarinic receptors in the toad urothelial cell line TBM-54 following acrolein treatment.

  Clinical and experimental pharmacology & physiology 20080201

• Functional expression of M3, a muscarinic acetylcholine receptor subtype, in taste bud cells of mouse fungiform papillae.

  Chemical senses 20080101

• Anti-brain cholinergic auto antibodies from primary Sjögren syndrome sera modify simultaneously cerebral nitric oxide and prostaglandin biosynthesis.

  International immunopharmacology 20071205

• Muscarinic preferential M(1) receptor antagonists enhance the discriminative-stimulus effects of cocaine in rats.

  Pharmacology, biochemistry, and behavior 20071001

• Ocular permeability of pirenzepine hydrochloride enhanced by methoxy poly(ethylene glycol)-poly(D, L-lactide) block copolymer.

  Drug development and industrial pharmacy 20071001

• The time course of transmitter release in mouse motor nerve terminals is differentially affected by activation of muscarinic M1 or M2 receptors.

  The European journal of neuroscience 20071001

• Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease.

  Neurobiology of aging 20070901

• Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy.

  Movement disorders : official journal of the Movement Disorder Society 20070815

• Human idiopathic and neurogenic overactive bladders and the role of M2 muscarinic receptors in contraction.

  European urology 20070801

• Vitamin A deficiency increases airway resistance following C-fiber stimulation.

  Respiratory physiology & neurobiology 20070801

• Antagonism of nucleus accumbens M(2) muscarinic receptors disrupts operant responding for sucrose under a progressive ratio reinforcement schedule.

  Behavioural brain research 20070719

• Muscarinic M2 receptor inhibition of calcium current in rat nucleus tractus solitarius.

  Neuroreport 20070716

• Roles of muscarinic receptor subtypes in small intestinal motor dysfunction in acute radiation enteritis.

  American journal of physiology. Gastrointestinal and liver physiology 20070701

• Estimation of agonist activity at G protein-coupled receptors: analysis of M2 muscarinic receptor signaling through Gi/o,Gs, and G15.

  The Journal of pharmacology and experimental therapeutics 20070601

• Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia.

  Biological psychiatry 20070515

• Olanzapine treatment decreases the density of muscarinic M2 receptors in the dorsal vagal complex of rats.

  Progress in neuro-psychopharmacology & biological psychiatry 20070509

• Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice.

  Psychopharmacology 20070501

• Opposing short- and long-term effects on muscarinic M1/4 receptor binding following chronic phencyclidine treatment.

  Journal of neuroscience research 20070501

• M1 muscarinic receptor modulation of Kir2 channels enhances temporal summation of excitatory synaptic potentials in prefrontal cortex pyramidal neurons.

  Journal of neurophysiology 20070501

• Muscarinic receptor-independent activation of cyclic adenosine monophosphate-dependent protein kinase in rostral ventrolateral medulla underlies the sympathoexcitatory phase of cardiovascular responses during mevinphos intoxication in the rat.

  Shock (Augusta, Ga.) 20070501

• Paradoxical effect of salbutamol in a model of acute organophosphates intoxication in guinea pigs: role of substance P release.

  American journal of physiology. Lung cellular and molecular physiology 20070401

• Corticotropin-releasing factor inhibition of sheep fetal colonic contractility: mechanisms to prevent meconium passage in utero.

  American journal of obstetrics and gynecology 20070401

• Insect muscarinic acetylcholine receptor: pharmacological and toxicological profiles of antagonists and agonists.

  Journal of agricultural and food chemistry 20070321

• Effects of typical and atypical antipsychotic drugs on rat brain muscarinic receptors.

  Neurochemical research 20070301

• In vitro effects of bethanechol on specimens of intestinal smooth muscle obtained from the duodenum and jejunum of healthy dairy cows.

  American journal of veterinary research 20070301

• Activation of hippocampal postsynaptic muscarinic receptors is involved in long-term spatial memory formation.

  The European journal of neuroscience 20070301

• Aging-induced decrease of cholinergic response and calcium sensitivity on rat jejunum contractions.

  The journals of gerontology. Series A, Biological sciences and medical sciences 20070301

• Glutamatergic synaptic depression by synthetic amyloid beta-peptide in the medial septum.

  Journal of neuroscience research 20070215

• Muscarinic type 1 receptors mediate part of nitric oxide's vagal facilitatory effect in the isolated innervated rat right atrium.

  Nitric oxide : biology and chemistry 20070201

• In vitro characterization of parasympathetic and sympathetic responses in cyclophosphamide-induced cystitis in the rat.

  Basic & clinical pharmacology & toxicology 20070201

• Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia.

  Progress in neuro-psychopharmacology & biological psychiatry 20070130

• Functional roles of muscarinic M2 and M3 receptors in mouse stomach motility: studies with muscarinic receptor knockout mice.

  European journal of pharmacology 20070112

• Muscarinic receptor subtypes mediating positive and negative inotropy in the developing chick ventricle.

  Journal of pharmacological sciences 20070101

• [The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors].

  Klinicheskaia meditsina 20070101

• [Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20070101

• Serum levels of olanzapine and its N-desmethyl and 2-hydroxymethyl metabolites in child and adolescent psychiatric disorders: effects of dose, diagnosis, age, sex, smoking, and comedication.

  Therapeutic drug monitoring 20061201

• M3 muscarinic receptor-deficient mice retain bethanechol-mediated intestinal ion transport and are more sensitive to colitis.

  Canadian journal of physiology and pharmacology 20061101

• Muscarinic regulation of neonatal rat bladder spontaneous contractions.

  American journal of physiology. Regulatory, integrative and comparative physiology 20061001

• Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.

  Neurobiology of aging 20060901

• Selective blockade of central m1 muscarinic cholinergic receptors with pirenzepine impairs cardiovascular and respiratory function in rats with acute hemorrhage.

  Bulletin of experimental biology and medicine 20060901

• Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors.

  Autonomic & autacoid pharmacology 20060701

• Agonist and antagonist sensitivity of non-selective cation channel currents evoked by muscarinic receptor stimulation in bovine ciliary muscle cells.

  Autonomic & autacoid pharmacology 20060701

• Muscarinic cholinoceptor activation modulates DNA synthesis and CD40 expression in fibroblast cells.

  Autonomic & autacoid pharmacology 20060701

• Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine.

  Neuropharmacology 20060601

• [Corneal permeability of topically applied pirenzepine solution].

  [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20060601

• Cardiac activity and blood pressure in rats during selective blockade of various subtypes of muscarinic cholinoceptors.

  Bulletin of experimental biology and medicine 20060601

• Distribution and function of muscarinic receptor subtypes in the ovine submandibular gland.

  Journal of applied physiology (Bethesda, Md. : 1985) 20060401

• Muscarinic autoreceptors modulate transmitter release through protein kinase C and protein kinase A in the rat motor nerve terminal.

  The European journal of neuroscience 20060401

• M1 muscarinic receptors contribute to, whereas M4 receptors inhibit, dopamine D1 receptor-induced [3H]-cyclic AMP accumulation in rat striatal slices.

  Neurochemical research 20060401

• Pharmacological characterization of muscarinic receptor subtypes mediating vasoconstriction of human umbilical vein.

  British journal of pharmacology 20060301

• Cholinergic receptor subtypes in the olfactory bulbectomy model of depression.

  Brain research bulletin 20060130

• Expression and localization of muscarinic acetylcholine receptor subtypes in rat efferent ductules and epididymis.

  Cell and tissue research 20060101

• Effects of pirenzepine on Dai-kenchu-to-induced elevation of the plasma neuropeptide levels in humans.

  Biological & pharmaceutical bulletin 20060101

• Effects of atropine and pirenzepine on heart rate turbulence.

  Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20060101

• [Effect of pirenzepine on form deprivation myopia in chicks and its possible mechanism].

  [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20060101

• A rapid and versatile method to label receptor ligands using 'click' chemistry: Validation with the muscarinic M1 antagonist pirenzepine.

  Bioconjugate chemistry 20060101

• Allosteric modulators and selective agonists of muscarinic receptors.

  Journal of molecular neuroscience : MN 20060101

• N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.

  Bioorganic & medicinal chemistry letters 20051215

• On the use of nonfluorescent dye labeled ligands in FRET-based receptor binding studies.

  Journal of medicinal chemistry 20051201

• In vitro effects of bethanechol on equine gastrointestinal contractility and functional characterization of involved muscarinic receptor subtypes.

  Journal of veterinary pharmacology and therapeutics 20051201

• A retrospective comparison of cumulative time spent in remission during treatment with olanzapine or risperidone among patients with schizophrenia.

  Schizophrenia research 20051115

• Cooperative glutamatergic and cholinergic mechanisms generate short-term modifications of synaptic effectiveness in prepositus hypoglossi neurons.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20051026

• Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia.

  Journal of neuroscience research 20050915

• Idiopathic facial paralysis (Bell's palsy) in the immediate puerperium in a patient with mild preeclampsia: a case report.

  Archives of gynecology and obstetrics 20050901

• HPLC determination of pirenzepine dihydrochloride in rabbit aqueous humor.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050805

• Excitatory effect of M1 muscarinic acetylcholine receptor on automaticity of mouse heart.

  Archives of pharmacal research 20050801

• The anti-inflammatory effect of peripheral bee venom stimulation is mediated by central muscarinic type 2 receptors and activation of sympathetic preganglionic neurons.

  Brain research 20050712

• Choto-san, a Kampo formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor.

  Pharmacology, biochemistry, and behavior 20050701

• Expression of muscarinic acetylcholine receptors (M1-, M2-, M3- and M4-type) in the neuromuscular junction of the newborn and adult rat.

  Histology and histopathology 20050701

• The effects of microinjection of the selective blocker of muscarinic M1 receptors pirenzepine into the neostriatum on the motor behavior of rats.

  Neuroscience and behavioral physiology 20050701

• Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies.

  Behavioural brain research 20050620

• Cholinergically stimulated gastric acid secretion is mediated by M(3) and M(5) but not M(1) muscarinic acetylcholine receptors in mice.

  American journal of physiology. Gastrointestinal and liver physiology 20050601

• Regional differences in cholinergic regulation of potassium current in feline esophageal circular smooth muscle.

  American journal of physiology. Gastrointestinal and liver physiology 20050601

• A high n-6 polyunsaturated fatty acid diet reduces muscarinic M2/M4 receptor binding in the rat brain.

  Journal of chemical neuroanatomy 20050601

• M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders.

  Brain research bulletin 20050515

• 5-HT2A and muscarinic receptors in schizophrenia: a postmortem study.

  Neuroscience letters 20050513

• Effects of (+/-)-huprine Y and (+/-)-huprine Z, two new anticholinesterasic drugs, on muscarinic receptors.

  Neuroscience letters 20050506

• Ketamine reduces cholinergic modulated GABA release from rat striatal slices.

  Toxicology letters 20050428

• Effect of pirenzepine ophthalmic solution on form-deprivation myopia in the guinea pigs.

  Chinese medical journal 20050405

• Signal transduction underlying carbachol-induced PGE2 generation and cox-1 mRNA expression of rat brain.

  Neuropharmacology 20050401

• A pentylenetetrazole-induced generalized seizure in early life enhances the efficacy of muscarinic receptor coupling to G-protein in hippocampus and neocortex of adult rat.

  The European journal of neuroscience 20050401

• Effects of AF-DX116 and other muscarinic receptor antagonists on orthostatic hypotension in autonomic imbalanced (SART-stressed) rats.

  Journal of pharmacological sciences 20050301

• Expression of muscarinic acetylcholine receptors and choline acetyltransferase enzyme in cultured antennal sensory neurons and non-neural cells of the developing moth Manduca sexta.

  Journal of neurobiology 20050215

• Fluoxetine disrupts the integration of anxiety and aversive memories.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050201

• Spatial memory in aged rats is related to PKCgamma-dependent G-protein coupling of the M1 receptor.

  Neurobiology of aging 20050101

• One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia.

  Ophthalmology 20050101

• Evaluation of drug-muscarinic receptor affinities using cell membrane chromatography and radioligand binding assay in guinea pig jejunum membrane.

  Acta pharmacologica Sinica 20050101

• [Blood circulation and secretory function in the gastric mucosa during inhibition of M1-cholinergic receptors and L-Ca2+-channels].

  Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 20050101

• Smoking during early pregnancy affects the expression pattern of both nicotinic and muscarinic acetylcholine receptors in human first trimester brainstem and cerebellum.

  Neuroscience 20050101

• [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].

  Khirurgiia 20050101

• [Fundamentals of modern treatment of myopia].

  Annales Academiae Medicae Stetinensis 20050101

• Protective effect of rhynchophylline and isorhynchophylline on in vitro ischemia-induced neuronal damage in the hippocampus: putative neurotransmitter receptors involved in their action.

  Life sciences 20041203

• [Participation of the neostriatum transmission system in automation of motor skills in dogs].

  Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20041201

• Characterization of functional effects of Z-338, a novel gastroprokinetic agent, on the muscarinic M1, M2, and M3 receptors expressed in Xenopus oocytes.

  European journal of pharmacology 20041128

• Intrathecal clonidine inhibits mechanical allodynia via activation of the spinal muscarinic M1 receptor in streptozotocin-induced diabetic mice.

  European journal of pharmacology 20041128

• Mechanisms mediating cholinergic antral circular smooth muscle contraction in rats.

  World journal of gastroenterology 20041115

• Altered emotional behaviors and the expression of 5-HT1A and M1 muscarinic receptors in micro-opioid receptor knockout mice.

  Synapse (New York, N.Y.) 20041101

• Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: a 1-year, multicenter, double-masked, placebo-controlled parallel study.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20041101

• The effects on place cells of local scopolamine dialysis are mimicked by a mixture of two specific muscarinic antagonists.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20041020

• Muscarinic antagonist control of myopia: a molecular search for the M1 receptor in chick.

  Molecular vision 20041013

• Cholinergic regulation of the evoked quantal release at frog neuromuscular junction.

  The Journal of physiology 20041001

• Effects of pirenzepine on pupil size and accommodation in rhesus monkeys.

  Investigative ophthalmology & visual science 20041001

• Differential effects of M1 muscarinic receptor blockade and nicotinic receptor blockade in the dorsomedial striatum on response reversal learning.

  Behavioural brain research 20040923

• A study of matrix effects on an LC/MS/MS assay for olanzapine and desmethyl olanzapine.

  Journal of pharmaceutical and biomedical analysis 20040903

• Distinct properties of carbachol- and DHPG-induced network oscillations in hippocampal slices.

  Neuropharmacology 20040901

• Fluorescent pirenzepine derivatives as potential bitopic ligands of the human M1 muscarinic receptor.

  Journal of medicinal chemistry 20040812

• Maternal exposure to nicotine and chlorpyrifos, alone and in combination, leads to persistently elevated expression of glial fibrillary acidic protein in the cerebellum of the offspring in late puberty.

  Archives of toxicology 20040801

• M1 receptor agonism, a possible treatment for cognitive deficits in schizophrenia.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040801

• Inhibitory effect of fentanyl on acetylcholine-induced relaxation in rat aorta.

  Anesthesiology 20040701

• Development of a new type of allosteric modulator of muscarinic receptors: hybrids of the antagonist AF-DX 384 and the hexamethonio derivative W84.

  Journal of medicinal chemistry 20040603

• Effects of anticholinergic drugs selective for muscarinic receptor subtypes on prepulse inhibition in mice.

  European journal of pharmacology 20040525

• Acetylcholine regulates ghrelin secretion in humans.

  The Journal of clinical endocrinology and metabolism 20040501

• Reduction of clozapine-induced hypersalivation by pirenzepine is safe.

  Pharmacopsychiatry 20040301

• Contractile effect of acetylcholine on isolated isthmic segment of fallopian tubes.

  Methods and findings in experimental and clinical pharmacology 20040301

• [Effect of microinjections of a selective blocker of M1-muscarinic receptors pirenzepine into the neostriatum on the rat motor activity].

  Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20040201

• Chlorpyrifos exposure during neurulation: cholinergic synaptic dysfunction and cellular alterations in brain regions at adolescence and adulthood.

  Brain research. Developmental brain research 20040131

• High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia.

  Biological psychiatry 20040115

• A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040101

• Contractile effect of acetylcholine on isolated ampullar segment of Fallopian tubes.

  Pharmacological research 20040101

• An automated blood sampler for simultaneous sampling of systemic blood and brain microdialysates for drug absorption, distribution, metabolism, and elimination studies.

  Journal of pharmacological and toxicological methods 20040101

• Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia.

  Progress in neuro-psychopharmacology & biological psychiatry 20040101

• Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States.

  Journal of the American Medical Directors Association 20040101

• Aging-related alterations in the contractile responses to acetylcholine, muscarinic cholinoceptors and cholinesterase activities in jejunum and colon of the male Fischer 344 rats.

  Experimental gerontology 20040101

• M2 muscarinic receptors in pontine reticular formation of C57BL/6J mouse contribute to rapid eye movement sleep generation.

  Neuroscience 20040101

• [Participation of the inhibitory mechanisms in the gastric hypersecretion caused by overproduction of glucocorticoids].

  Patologicheskaia fiziologiia i eksperimental'naia terapiia 20040101

• Activation of muscarinic acetylcholine receptors elicits pigment granule dispersion in retinal pigment epithelium isolated from bluegill.

  BMC neuroscience 20040101

• Characterization of fluoxetine plus olanzapine treatment in rats: a behavior, endocrine, and immediate-early gene expression analysis.

  Synapse (New York, N.Y.) 20031215

• Pulmonary embolism possibly associated with olanzapine treatment.

  BMJ (Clinical research ed.) 20031213

• Chinese medicinal herbs Muh-Shiang Bin-Lang-Wan increases the motility of sphincter of Oddi in anesthetized rabbits through activation of M1 muscarinic receptors.

  Life sciences 20031212

• Schizophrenia and Parkinson's disease lead to equal motor-related changes in cortical and subcortical brain activation: an fMRI fingertapping study.

  Psychiatry and clinical neurosciences 20031201

• Rapid onset of dyskinesia induced by olanzapine.

  Psychiatry and clinical neurosciences 20031201

• Applicability of an assay for routine monitoring of highly variable concentrations of olanzapine based on HPLC with mass spectrometric detection.

  Clinical chemistry 20031201

• Investigation of target plasma concentration-effect relationships for olanzapine in schizophrenia.

  Therapeutic drug monitoring 20031201

• Pharmacologic management of psychosis in the elderly: a critical review.

  Journal of geriatric psychiatry and neurology 20031201

• A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.

  Archives of general psychiatry 20031201

• Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp.

  The Journal of clinical endocrinology and metabolism 20031201

• Olanzapine induces insulin resistance: results from a prospective study.

  The Journal of clinical psychiatry 20031201

• Differential modulation of muscarinic receptors in the rat brain by repeated exposure to methyl parathion.

  The Journal of toxicological sciences 20031201

• [Gastrozepin: is its oblivion fair?].

  Klinichna khirurhiia 20031201

• Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.

  JAMA 20031126

• Neurocognitive performance and clinical changes in olanzapine-treated patients with schizophrenia.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20031101

• Up-regulation of spinal muscarinic receptors and increased antinociceptive effect of intrathecal muscarine in diabetic rats.

  The Journal of pharmacology and experimental therapeutics 20031101

• Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20031101

• Haloperidol, but not olanzapine, impairs cognitive performance after traumatic brain injury in rats.

  American journal of physical medicine & rehabilitation 20031101

• Olanzapine effects on auditory sensory gating in schizophrenia.

  The American journal of psychiatry 20031101

• Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

  Archives of general psychiatry 20031101

• Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial.

  International journal of geriatric psychiatry 20031101

• Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study.

  The Journal of clinical psychiatry 20031101

• [Neuroleptic malignant syndrome in a patient treated with olanzapine].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20031023

• Electrophysiological effects of acute and chronic olanzapine and fluoxetine in the rat prefrontal cortex.

  Neuroscience letters 20031009

• Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20031001

• Olanzapine in Chinese treatment-resistant patients with schizophrenia: an open-label, prospective trial.

  Psychiatry and clinical neurosciences 20031001

• Schizophrenia, VI: Treatments.

  The American journal of psychiatry 20031001

• Racial disparity in the use of atypical antipsychotic medications among veterans.

  The American journal of psychiatry 20031001

• The effect of olanzapine on anxiety among patients with schizophrenia: preliminary findings.

  Journal of clinical psychopharmacology 20031001

• The relationship of changes in leptin, neuropeptide Y and reproductive hormones to antipsychotic induced weight gain.

  Human psychopharmacology 20031001

• Retrospective study of hepatic enzyme elevations in children treated with olanzapine, divalproex, and their combination.

  Journal of the American Academy of Child and Adolescent Psychiatry 20031001

• Pilot study: access to fitness facility and exercise levels in olanzapine-treated patients.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20031001

• Fungal dermatitis with olanzapine in schizophrenia.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20031001

• High-dose olanzapine and prolactin levels.

  The Journal of clinical psychiatry 20031001

• Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.

  The Journal of clinical psychiatry 20031001

• Divalproex versus olanzapine in mania.

  The Journal of clinical psychiatry 20031001

• Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study.

  Psychopharmacology 20030901

• Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol.

  Psychopharmacology 20030901

• Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment.

  The Journal of pharmacology and experimental therapeutics 20030901

• Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia.

  Psychopharmacology 20030901

• Antipsychotic drugs differentially modulate apolipoprotein D in rat brain.

  Journal of neurochemistry 20030901

• Objective and subjective efficacy as well as tolerability of olanzapine in the acute treatment of 120 patients with schizophrenia spectrum disorders.

  International clinical psychopharmacology 20030901

• Risperidone and olanzapine in adults with intellectual disability: a clinical naturalistic study.

  International clinical psychopharmacology 20030901

• Olanzapine and venous thromboembolism.

  International clinical psychopharmacology 20030901

• Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.

  The Annals of pharmacotherapy 20030901

• Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder.

  International journal of geriatric psychiatry 20030901

• Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.

  The Journal of clinical psychiatry 20030901

• Reducing the risk for suicide in schizophrenia and affective disorders.

  The Journal of clinical psychiatry 20030901

• Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.

  The Journal of clinical psychiatry 20030901

• Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial.

  Biological psychiatry 20030815

• Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome.

  Biological psychiatry 20030815

• Comparison of the effects of antipsychotics on a delayed radial maze task in the rat.

  Psychopharmacology 20030801

• Bilateral lesions of the entorhinal cortex differentially modify haloperidol- and olanzapine-induced c-fos mRNA expression in the rat forebrain.

  Neuropharmacology 20030801

• Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide.

  Journal of neuroscience research 20030801

• Olanzapine pharmacokinetics are similar in Chinese and Caucasian subjects.

  British journal of clinical pharmacology 20030801

• Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.

  The American journal of psychiatry 20030801

• Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants.

  The American journal of psychiatry 20030801

• Antipsychotic-induced weight gain: bipolar disorder and leptin.

  Journal of clinical psychopharmacology 20030801

• Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation.

  Journal of clinical psychopharmacology 20030801

• Olanzapine versus placebo in acute mania: treatment responses in subgroups.

  Journal of clinical psychopharmacology 20030801

• A Canadian multicenter trial assessing memory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapine.

  Journal of clinical psychopharmacology 20030801

• Potential use of olanzapine in treatment of substance dependence disorders.

  Journal of clinical psychopharmacology 20030801

• Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine.

  Pharmacotherapy 20030801

• Comparison of three antipsychotics in the emergency psychiatric setting.

  Human psychopharmacology 20030801

• Effect of nizatidine on olanzapine-associated weight gain in schizophrenic patients in Korea: a pilot study.

  Human psychopharmacology 20030801

• Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain.

  Human psychopharmacology 20030801

• Eruptive xanthomas associated with olanzapine use.

  Archives of dermatology 20030801

• An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.

  The Journal of clinical psychiatry 20030801

• Olanzapine for cocaine cravings and relapse prevention.

  The Journal of clinical psychiatry 20030801

• Olanzapine-associated bilateral pedal edema.

  The Journal of clinical psychiatry 20030801

• Miniaturization of fluorescence polarization receptor-binding assays using CyDye-labeled ligands.

  Journal of biomolecular screening 20030801

• Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20030716

• [Type 2 diabetes and dyslipidemia. Side effects of 'Atypical' neuroleptics?].

  Medizinische Klinik (Munich, Germany : 1983) 20030715

• Deficits in avoidance responding after paradoxical sleep deprivation are not associated with altered [3H]pirenzepine binding to M1 muscarinic receptors in rat brain.

  Brain research 20030704

• Change in muscarinic modulation of transmitter release in the rat urinary bladder after spinal cord injury.

  Neurochemistry international 20030701

• Olanzapine's effects to reduce fear and anxiety and enhance social interactions coincide with increased progestin concentrations of ovariectomized rats.

  Psychoneuroendocrinology 20030701

• Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.

  Schizophrenia research 20030701

• The combination of olanzapine and fluoxetine in mood disorders.

  Expert opinion on pharmacotherapy 20030701

• Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.

  The American journal of psychiatry 20030701

• Alpha2-adrenoceptor antagonism is neither sufficient nor necessary for the distinctive action of atypical neuroleptics on intracranial self-stimulation in the rat.

  Behavioural pharmacology 20030701

• Olanzapine treatment of an adolescent girl with anorexia nervosa.

  Human psychopharmacology 20030701

• [A case of delusional parasitosis in severe heart failure. Olanzapine within the framework of a multimodal therapy].

  Der Nervenarzt 20030701

• [Life threatening neuroleptic malignant syndrome due to olanzapine].

  Psychiatrische Praxis 20030701

• A review of olanzapine-associated toxicity and fatality in overdose.

  Journal of psychiatry & neuroscience : JPN 20030701

• Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects.

  Journal of psychiatry & neuroscience : JPN 20030701

• Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients.

  The Journal of clinical psychiatry 20030701

• The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder.

  The Journal of clinical psychiatry 20030701

• Olanzapine/risperidone and diabetes risk.

  The Journal of clinical psychiatry 20030701

• Nonalcoholic steatohepatitis: a possible side effect of atypical antipsychotics.

  The Journal of clinical psychiatry 20030701

• Fluoxetine augmentation with olanzapine for treatment of chronic resistant depression in an elderly patient: a case report.

  The Journal of clinical psychiatry 20030701

• Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia.

  Southern medical journal 20030701

• Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.

  Southern medical journal 20030701

• Olanzapine and hypoglycemic coma in a frail elderly woman. A case report.

  Pharmacopsychiatry 20030701

• Antipsychotic medication and seizures: a review.

  Drugs of today (Barcelona, Spain : 1998) 20030701

• A pilot trial of olanzapine for the treatment of cocaine dependence.

  Drug and alcohol dependence 20030605

• Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activation.

  The Journal of pharmacology and experimental therapeutics 20030601

• Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs.

  Psychopharmacology 20030601

• Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand.

  Schizophrenia research 20030601

• Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity.

  Journal of neuroscience research 20030601

• Olanzapine induced neuroleptic malignant syndrome--a case review.

  Human psychopharmacology 20030601

• Treatment of cervical dystonia by olanzapine.

  Human psychopharmacology 20030601

• Nonketotic hyperosmolar syndrome from olanzapine, lithium, and valproic acid cotreatment.

  The Annals of pharmacotherapy 20030601

• Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.

  Bipolar disorders 20030601

• Flushing and sweating in an advanced breast cancer patient relieved by olanzapine.

  Journal of pain and symptom management 20030601

• Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.

  Journal of pain and symptom management 20030601

• Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20030601

• Safety, effectiveness, and quality of life of olanzapine in first-episode schizophrenia: a naturalistic study.

  Progress in neuro-psychopharmacology & biological psychiatry 20030601

• Use of atypical antipsychotic drugs in patients with dementia.

  American family physician 20030601

• Ethnic differences in use of antipsychotic medication among Texas medicaid clients with schizophrenia.

  The Journal of clinical psychiatry 20030601

• Chlorpromazine equivalent doses for the newer atypical antipsychotics.

  The Journal of clinical psychiatry 20030601

• A double-blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities.

  The Journal of clinical psychiatry 20030601

• Hypothermia in a hemodialysis patient treated with olanzapine monotherapy.

  Journal of clinical psychopharmacology 20030601

• A tolerability study of pirenzepine ophthalmic gel in myopic children.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20030601

• QTc prolongation: chlorpromazine and high-dosage olanzapine.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030601

• Should lipids be monitored during the first year of treatment with an atypical antipsychotic?

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030601

• Potential risk of diabetes mellitus with the use of atypical antipsychotic medication.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030601

• Treatment noncompliance with orally disintegrating olanzapine tablets.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030601

• Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia.

  The international journal of neuropsychopharmacology 20030601

• [Effects of pirenzepine on lens-induced myopia in the guinea-pig].

  [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 20030601

• Atypical neuroleptics and diabetes.

  Diabetes & metabolism 20030601

• [Rhabdomyolysis associated with respiratory infection in chronic psychiatric patients during neuroleptic treatment].

  Minerva anestesiologica 20030601

• [Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression].

  MMW Fortschritte der Medizin 20030526

• [Fast control of manic or mixed episodes. Atypical neuroleptics for bipolar patients].

  MMW Fortschritte der Medizin 20030526

• [Long-term therapy with intuition].

  MMW Fortschritte der Medizin 20030526

• Pharmacological approaches to the management of schizophrenia.

  The Medical journal of Australia 20030505

• 6beta-acetoxy nortropane regulated processing of amyloid precursor protein in CHOm1 cells and rat brain.

  European journal of pharmacology 20030502

• Correlation of cytochrome P450 (CYP) 1A2 activity using caffeine phenotyping and olanzapine disposition in healthy volunteers.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030501

• The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design.

  Schizophrenia research 20030501

• The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the 'prodromal' sample.

  Schizophrenia research 20030501

• Brain muscarinic receptor subtypes mediating water intake and Fos following cerebroventricular administration of bethanecol in rats.

  Psychopharmacology 20030501

• Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat.

  Psychopharmacology 20030501

• Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients.

  Progress in neuro-psychopharmacology & biological psychiatry 20030501

• The influence of olanzapine on immune cells in patients with schizophrenia.

  Progress in neuro-psychopharmacology & biological psychiatry 20030501

• Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses.

  International clinical psychopharmacology 20030501

• The efficacy of olanzapine monotherapy for acute hypomania or mania in an outpatient setting.

  International clinical psychopharmacology 20030501

• Role of ethnicity in predicting antipsychotic medication adherence.

  The Annals of pharmacotherapy 20030501

• Effect of 2-week treatment with pirenzepine on fasting and postprandial glucose concentrations in individuals with type 2 diabetes.

  Diabetes care 20030501

• Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade.

  Journal of cardiovascular pharmacology 20030501

• Cost evaluation of risperidone compared with olanzapine.

  Psychiatric services (Washington, D.C.) 20030501

• Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia.

  Journal of neural transmission (Vienna, Austria : 1996) 20030501

• A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patients.

  Journal of pain and symptom management 20030501

• Anti-cataleptic effects of clozapine, but not olanzapine and quetiapine, on SCH 23390- or raclopride-induced catalepsy in rats.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20030501

• Long-term effectiveness of risperidone and olanzapine in resistant or intolerant schizophrenic patients. A mirror study.

  Acta psychiatrica Scandinavica 20030501

• Olanzapine in the treatment-resistant, combat-related PTSD--a series of case reports.

  Acta psychiatrica Scandinavica 20030501

• Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.

  The Journal of clinical psychiatry 20030501

• Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysis.

  The Journal of clinical psychiatry 20030501

• Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

  The Journal of clinical psychiatry 20030501

• Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder.

  The Journal of clinical psychiatry 20030501

• The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia.

  International journal of geriatric psychiatry 20030501

• Castration decreases amylase release associated with muscarinic acetylcholine receptor downregulation in rat parotid gland.

  British journal of pharmacology 20030501

• Inpatient length of stay and atypical antipsychotic use among elderly patients with psychiatric disorders and Alzheimer's disease.

  Managed care interface 20030501

• Spontaneously hypertensive rats: further evaluation of age-related memory performance and cholinergic marker expression.

  Journal of psychiatry & neuroscience : JPN 20030501

• Cholinergic modulation of memory in the basolateral amygdala involves activation of both m1 and m2 receptors.

  Behavioural pharmacology 20030501

• A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine.

  Behavioural pharmacology 20030501

• Haloperidol-induced dyskinesia is associated with striatal NO synthase suppression: reversal with olanzapine.

  Behavioural pharmacology 20030501

• Calming versus sedative effects of intramuscular olanzapine in agitated patients.

  The American journal of emergency medicine 20030501

• A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy.

  Clinical therapeutics 20030501

• [Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].

  Psychiatrische Praxis 20030501

• [Neuroleptics and cognition].

  Psychiatrische Praxis 20030501

• [3-D ultrasound-assisted gait analysis of schizophrenic patients. Comparison between conventional neuroleptics and olanzapine].

  Psychiatrische Praxis 20030501

• Comparison of the pharmacological antagonism of M2 and M3 muscarinic receptors expressed in isolation and in combination.

  Biochemical pharmacology 20030415

• Characterization of muscarinic receptor subtypes in the rostral ventrolateral medulla and effects on morphine-induced antinociception in rats.

  European journal of pharmacology 20030404

• Economic evaluations of novel antipsychotic medications: a literature review.

  Schizophrenia research 20030401

• The efficacy and safety of olanzapine for the treatment of geriatric psychosis.

  Journal of clinical psychopharmacology 20030401

• Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine.

  Journal of clinical psychopharmacology 20030401

• Acute dysphoric mania: treatment response to olanzapine versus placebo.

  Journal of clinical psychopharmacology 20030401

• Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials.

  Psychoneuroendocrinology 20030401

• Clinical trial response and dropout rates with olanzapine versus risperidone.

  The Annals of pharmacotherapy 20030401

• Olanzapine and serotonin toxicity.

  Psychiatry and clinical neurosciences 20030401

• Neuroleptic malignant syndrome and low-dose olanzapine.

  The American journal of psychiatry 20030401

• Improving identification of treatment effectiveness in bipolar disorders.

  Bipolar disorders 20030401

• Assessment of treatment response in mania: commentary and new findings.

  Bipolar disorders 20030401

• Olanzapine elevation of serum creatine kinase.

  The Journal of clinical psychiatry 20030401

• Effect of olanzapine on the liver transaminases.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030401

• Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human.

  Pharmacology, biochemistry, and behavior 20030401

• Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders.

  Clinical therapeutics 20030401

• Olanzapine for intractable nausea in palliative care patients.

  Journal of palliative medicine 20030401

• Report of three case studies with olanzapine for chronic pain.

  The journal of pain : official journal of the American Pain Society 20030401

• The M4 muscarinic receptor-selective effects on keratinocyte crawling locomotion.

  Life sciences 20030328

• The presence and functions of muscarinic receptors in human T cells: the involvement in IL-2 and IL-2 receptor system.

  Life sciences 20030328

• Do atypical antipsychotics fail to exert cognitive sparing effects?

  Neuroreport 20030303

• Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol.

  Schizophrenia research 20030301

• The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment.

  Acta psychiatrica Scandinavica 20030301

• The role of cortical cholinergic pre- and post-synaptic receptors in taste memory formation.

  Neurobiology of learning and memory 20030301

• Olanzapine toxicity in unconjugated hyperbilirubinaemia (Gilbert's syndrome).

  The British journal of psychiatry : the journal of mental science 20030301

• Comparative effectiveness of antipsychotic drugs.

  The American journal of psychiatry 20030301

• Comparative effectiveness of antipsychotic drugs.

  The American journal of psychiatry 20030301

• Comparative effectiveness of antipsychotic drugs.

  The American journal of psychiatry 20030301

• Olanzapine treatment of anorexia nervosa: a retrospective study.

  The International journal of eating disorders 20030301

• Treatment of weight gain with fluoxetine in olanzapine-treated schizophrenic outpatients.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030301

• Olanzapine and risperidone.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030301

• Psychosis associated with interferon alfa therapy for chronic hepatitis B.

  The Annals of pharmacotherapy 20030301

• Olanzapine and clozapine but not haloperidol reverse subchronic phencyclidine-induced functional hyperactivity of N-methyl-D-aspartate receptors in pyramidal cells of the rat medial prefrontal cortex.

  Neuropharmacology 20030301

• Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze.

  Neuropharmacology 20030301

• Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20030301

• Successful therapy of tardive dyskinesia in a 71-year-old woman with a combination of tetrabenazine, olanzapine and tiapride.

  International journal of clinical practice 20030301

• The rebound excitation triggered by anticholinergic drugs from ovine pyloric antrum, small bowel and gallbladder.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20030301

• Treating acute mania.

  The Journal of family practice 20030301

• Treating bipolar depression.

  The Journal of family practice 20030301

• Long-term therapy of bipolar illness.

  The Journal of family practice 20030301

• Optimal dosing of medications (in bipolar disorder).

  The Journal of family practice 20030301

• Safety in treating bipolar disorder.

  The Journal of family practice 20030301

• Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.

  Journal of chemical neuroanatomy 20030301

• Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes.

  The Journal of clinical psychiatry 20030301

• A case report of olanzapine-induced fecal incontinence.

  The Journal of clinical psychiatry 20030301

• Rehospitalization risk with second-generation and depot antipsychotics.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20030301

• Stressor-like effects of cocaine on heat shock protein and stress-activated protein kinase expression in the rat hippocampus: interaction with ethanol and anti-toxicity drugs.

  Legal medicine (Tokyo, Japan) 20030301

• alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.

  European journal of pharmacology 20030221

• Acute hepatocellular-cholestatic liver injury after olanzapine therapy.

  Annals of internal medicine 20030218

• Scintillation proximity assay of inositol phosphates in cell extracts: high-throughput measurement of G-protein-coupled receptor activation.

  Analytical biochemistry 20030215

• Reply to Dr Mahendran. We have not found reported cases of [obsessive-compulsive] OC arising from de novo with olanzapine treatment.

  The Australian and New Zealand journal of psychiatry 20030201

• A prospective, open-label trial of olanzapine in adolescents with schizophrenia.

  Journal of the American Academy of Child and Adolescent Psychiatry 20030201

• Usefulness of olanzapine in refractory panic attacks.

  Journal of clinical psychopharmacology 20030201

• Olanzapine induced 'typical' neuroleptic malignant syndrome.

  Journal of clinical psychopharmacology 20030201

• Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication.

  Therapeutic drug monitoring 20030201

• Treatment with the atypical antipsychotic, olanzapine, prevents the expression of amphetamine-induced place conditioning in the rat.

  Progress in neuro-psychopharmacology & biological psychiatry 20030201

• Effects of olanzapine on auditory P300 in schizophrenia.

  Progress in neuro-psychopharmacology & biological psychiatry 20030201

• Efficacy should drive atypical antipsychotic treatment.

  BMJ (Clinical research ed.) 20030201

• Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.

  The American journal of psychiatry 20030201

• Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study.

  The American journal of psychiatry 20030201

• Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.

  The American journal of psychiatry 20030201

• Heterogeneity of presynaptic muscarinic receptors mediating inhibition of sympathetic transmitter release: a study with M2- and M4-receptor-deficient mice.

  British journal of pharmacology 20030201

• [Koro--discussing a transcultural psychopathological phenomenon].

  Fortschritte der Neurologie-Psychiatrie 20030201

• Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy.

  Pharmacotherapy 20030201

• Switching from depot antipsychotic drugs to olanzapine in patients with chronic schizophrenia.

  The Journal of clinical psychiatry 20030201

• Local-global processing in early-onset schizophrenia: evidence for an impairment in shifting the spatial scale of attention.

  Brain and cognition 20030201

• Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania.

  Bipolar disorders 20030201

• Tc-99 HMPAO SPECT study of regional cerebral blood flow in olanzapine-treated schizophrenic patients.

  European archives of psychiatry and clinical neuroscience 20030201

• Atypical psychotropic medications and their adverse effects: a review for the African-American primary care physician.

  Journal of the National Medical Association 20030201

• Effect of oxotremorine on resting membrane potential and cell volume in skeletal muscle fibers in rats after in vivo blockade of NO-synthase.

  Bulletin of experimental biology and medicine 20030201

• Measurement of simple reaction time in antipsychotic treatment of patients with schizophrenia.

  Wiener klinische Wochenschrift 20030131

• Cholinergic mechanism in the lateral septal area is involved in the stress-induced blood pressure increase in rats.

  Brain research bulletin 20030130

• Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients.

  Brain research 20030117

• [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].

  Nederlands tijdschrift voor geneeskunde 20030104

• New-onset diabetes and ketoacidosis with atypical antipsychotics.

  Schizophrenia research 20030101

• An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia.

  Schizophrenia research 20030101

• PMA decreases the proliferation of retinal cells in vitro: the involvement of acetylcholine and BDNF.

  Neurochemistry international 20030101

• Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: case reports.

  The International journal of eating disorders 20030101

• Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs.

  Journal of neuroscience research 20030101

• Role of hippocampal M1 and M4 muscarinic receptor subtypes in memory consolidation in the rat.

  Pharmacology, biochemistry, and behavior 20030101

• Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20030101

• Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors.

  The Journal of pharmacology and experimental therapeutics 20030101

• Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol.

  International clinical psychopharmacology 20030101

• Optimal dose of risperidone and olanzapine for patients with schizophrenia in Taiwan.

  International clinical psychopharmacology 20030101

• Peripheral oedema in patients taking olanzapine.

  International clinical psychopharmacology 20030101

• Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030101

• Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030101

• Valproic Acid and risperidone.

  Journal of the American Academy of Child and Adolescent Psychiatry 20030101

• Olanzapine-associated seizure.

  The Annals of pharmacotherapy 20030101

• Placebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania.

  Journal of affective disorders 20030101

• Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling.

  Journal of affective disorders 20030101

• Olanzepine-induced tardive dyskinesia.

  The British journal of psychiatry : the journal of mental science 20030101

• Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

  Archives of general psychiatry 20030101

• Olanzapine and haloperidol: potential for neutropenia?

  Psychosomatics 20030101

• Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.

  Clinical endocrinology 20030101

• Modulation of ACh release by presynaptic muscarinic autoreceptors in the neuromuscular junction of the newborn and adult rat.

  The European journal of neuroscience 20030101

• Olanzapine efficacy in the treatment of essential tremor.

  European journal of neurology 20030101

• Olanzapine for schizophrenia.

  The Cochrane database of systematic reviews 20030101

• Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine.

  Journal of neural transmission (Vienna, Austria : 1996) 20030101

• An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania.

  The Journal of clinical psychiatry 20030101

• QTc prolongation and high-dose olanzapine.

  Psychosomatics 20030101

• Olanzapine and quick-response hyperglycemia.

  Psychosomatics 20030101

• Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.

  Journal of sex & marital therapy 20030101

• New approaches to managing psychotic depression.

  The Journal of clinical psychiatry 20030101

• Difficult-to-treat depressions: a primary care perspective.

  The Journal of clinical psychiatry 20030101

• High-dose olanzapine for treatment-refractory schizophrenia.

  Clinical neuropharmacology 20030101

• [Proposal for Latin America of an algorithm for the management of agitated patients with olanzapine and its switch to oral administration].

  Vertex (Buenos Aires, Argentina) 20030101

• Selecting effective long-term treatment for bipolar patients: monotherapy and combinations.

  The Journal of clinical psychiatry 20030101

• Acute dystonia caused by low dosage of olanzapine.

  The Journal of neuropsychiatry and clinical neurosciences 20030101

• Heart transplantation and schizophrenia.

  Psychosomatics 20030101

• Uncommon side effects associated with olanzapine. A case report.

  Pharmacopsychiatry 20030101

• The European Schizophrenia Outpatient Health Outcomes Study: baseline findings across country and treatment.

  Acta psychiatrica Scandinavica. Supplementum 20030101

• Hyperglycemia from olanzapine treatment in adolescents.

  Journal of child and adolescent psychopharmacology 20030101

• Assessing antipsychotic effectiveness in dementia with the factor structure of the Psychogeriatric Dependency Rating Scale (PGDRS).

  Journal of the American Medical Directors Association 20030101

• Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients.

  PharmacoEconomics 20030101

• Olanzapine-associated priapism.

  Psychosomatics 20030101

• Olanzapine for corticosteroid-induced mood disorders.

  Psychosomatics 20030101

• Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia.

  Journal of the American Medical Directors Association 20030101

• The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients.

  Journal of the American Medical Directors Association 20030101

• Fever, delirium, autonomic instability, and monocytosis associated with olanzapine.

  Journal of postgraduate medicine 20030101

• [Protective effect of olanzapine in psychotic disorder induced by interferon-alpha].

  Recenti progressi in medicina 20030101

• [An introduction to antipsychotics].

  Ryoikibetsu shokogun shirizu 20030101

• [Manic phase (manic episode)].

  Ryoikibetsu shokogun shirizu 20030101

• [Randomized, open label study on the use of ranitidine at different doses for the management of weight gain associated with olanzapine administration].

  Vertex (Buenos Aires, Argentina) 20030101

• The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats.

  Neuropsychobiology 20030101

• Involvement of cholinoceptors in cadmium-induced endothelial dysfunction.

  Journal of basic and clinical physiology and pharmacology 20030101

• Quetiapine in the successful treatment of schizophrenia with comorbid alcohol and drug dependence: a case report.

  International journal of psychiatry in medicine 20030101

• Olanzapine alone or in combination for acute mania.

  The Cochrane database of systematic reviews 20030101

• Antipsychotic drugs and QT interval prolongation.

  The Psychiatric quarterly 20030101

• Psoriasis during therapy with olanzapine.

  European journal of dermatology : EJD 20030101

• Treatment of interferon-induced psychosis in patients with comorbid hepatitis C and HIV.

  Psychosomatics 20030101

• Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients.

  American journal of Alzheimer's disease and other dementias 20030101

• Hyperglycemia and hypertriglyceridemia in real world patients on antipsychotic therapy.

  American journal of therapeutics 20030101

• [Therapeutic options in manic states].

  L'Encephale 20030101

• Loxapine versus olanzapine in the treatment of delirium following traumatic brain injury.

  NeuroRehabilitation 20030101

• [Safety and efficacy of olanzapine versus perphenazine in patients with schizophrenia: results of multicenter, 18-week, double-blind clinical trial].

  Psychiatria polska 20030101

• The effects of an educational intervention on antipsychotic-induced weight gain.

  Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing 20030101

• 5-HT2A receptor promoter polymorphism, -1438G/A and negative symptom response to olanzapine in schizophrenia.

  Psychopharmacology bulletin 20030101

• Switching treatment-resistant patients with schizophrenia or schizoaffective disorder to olanzapine: a one-year open-label study with five-year follow-up.

  Current medical research and opinion 20030101

• Tuberous sclerosis with psychosis.

  Psychosomatics 20030101

• Study of sexuality-related characteristics in young adults with schizophrenia treated with novel neuroleptics and in a comparison group of young adults.

  Schizophrenia bulletin 20030101

• [Demyelinating disease].

  Ryoikibetsu shokogun shirizu 20030101

• [Brain tumor].

  Ryoikibetsu shokogun shirizu 20030101

• [Porphyria].

  Ryoikibetsu shokogun shirizu 20030101

• Neurotransmitter relationships in the hypoxia-challenged cat carotid body.

  Advances in experimental medicine and biology 20030101

• Optimal treatment project for schizophrenia: results from a randomized, controlled, longitudinal study.

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20030101

• A 1-year open-label trial of olanzapine in school-age children with schizophrenia.

  Journal of child and adolescent psychopharmacology 20030101

• Olanzapine treatment in chronic drug-resistant childhood-onset schizophrenia: an open-label study.

  Journal of child and adolescent psychopharmacology 20030101

• Similarities and differences among antipsychotics.

  The Journal of clinical psychiatry 20030101

• Acute and maintenance treatment of bipolar mania: the role of atypical antipsychotics.

  Bipolar disorders 20030101

• Does the cholinergic system modulate gastrointestinal slow waves during less active phases of migrating myoelectric complex in healthy rams?

  Folia medica Cracoviensia 20030101

• Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.

  Brain research 20021220

• D-fenfluramine-evoked serotonergic responses in olanzapine-treated schizophrenic patients.

  Psychiatry research 20021215

• 'Normalization' of brain activation in schizophrenia. An fMRI study.

  Schizophrenia research 20021201

• The colon-selective spasmolytic otilonium bromide inhibits muscarinic M(3) receptor-coupled calcium signals in isolated human colonic crypts.

  British journal of pharmacology 20021201

• Long-term effects of newer antipsychotic drugs on neuronal nitric oxide synthase in rat brain.

  Nitric oxide : biology and chemistry 20021201

• Effects of development on olanzapine-associated adverse events.

  Journal of the American Academy of Child and Adolescent Psychiatry 20021201

• Comparable dopamine 2 receptor occupancy.

  The American journal of psychiatry 20021201

• Switching outpatients with schizophrenia and related disorders on long-acting injectable antipsychotics to olanzapine: an open-label naturalistic pilot study.

  Journal of clinical psychopharmacology 20021201

• 5HT2A and 5HT2C receptor polymorphisms and predicting clinical response to olanzapine in schizophrenia.

  Journal of clinical psychopharmacology 20021201

• Differential effects of chronic haloperidol and olanzapine exposure on brain cholinergic markers and spatial learning in rats.

  Psychopharmacology 20021201

• Pharmacotherapy of bipolar disorder: the role of atypical antipsychotics and experimental strategies.

  Human psychopharmacology 20021201

• [Uncontrolled hyperglycemia with ketosis associated with olanzapine therapy].

  Revista clinica espanola 20021201

• Insulin sensitivity and lipolysis in adolescent girls with poorly controlled type 1 diabetes: effect of anticholinergic treatment.

  Clinical endocrinology 20021201

• The effects of excitotoxic hippocampal lesions in rats on risperidone- and olanzapine-induced locomotor suppression.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20021201

• Patient characteristics and prescription patterns of atypical antipsychotics among patients with schizophrenia.

  Journal of clinical pharmacy and therapeutics 20021201

• Sildenafil use in patients with olanzapine-induced erectile dysfunction.

  International journal of impotence research 20021201

• Recent developments in pharmacotherapy for the acutely psychotic patient.

  Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association 20021201

• Insight in persons with schizophrenia: effects of switching from conventional neuroleptics to atypical antipsychotics.

  Progress in neuro-psychopharmacology & biological psychiatry 20021201

• Characterization of olanzapine-induced weight gain in rats.

  Journal of psychopharmacology (Oxford, England) 20021201

• The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability.

  Journal of psychopharmacology (Oxford, England) 20021201

• Efficacy of olanzapine in social anxiety disorder: a pilot study.

  Journal of psychopharmacology (Oxford, England) 20021201

• Acute dystonic reaction in an elderly patient with mood disorder after titration of paroxetine: possible mechanisms and implications for clinical care.

  Journal of psychopharmacology (Oxford, England) 20021201

• The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis.

  The Journal of clinical psychiatry 20021201

• A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder.

  The Journal of clinical psychiatry 20021201

• An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.

  The Journal of clinical psychiatry 20021201

• Olanzapine treatment for patients with schizophrenia and cocaine abuse.

  The Journal of clinical psychiatry 20021201

• Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis.

  Chemico-biological interactions 20021110

• Myopia: attempts to arrest progression.

  The British journal of ophthalmology 20021101

• Treatment of severely psychotic inpatients with schizophrenia: olanzapine versus other antipsychotic drugs.

  International clinical psychopharmacology 20021101

• Weight gain associated with atypical antipsychotics.

  Journal of the American Academy of Child and Adolescent Psychiatry 20021101

• An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients.

  Archives of general psychiatry 20021101

• [Mnestic impairment under olanzapine overdosage in an elderly patient].

  Psychiatrische Praxis 20021101

• Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia.

  The Journal of clinical psychiatry 20021101

• Olanzapine-induced hair loss.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20021101

• Prescribing second-generation antipsychotics and the evolving standard of care in Italy.

  Pharmacopsychiatry 20021101

• Olanzapine and improvement of tardive dyskinesia.

  European psychiatry : the journal of the Association of European Psychiatrists 20021101

• Can olanzapine be implicated in causing serotonin syndrome?

  Psychiatry and clinical neurosciences 20021001

• Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study.

  Schizophrenia research 20021001

• Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol.

  Schizophrenia research 20021001

• Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients.

  Schizophrenia research 20021001

• Visual inspection of medications in preventing unexplained relapses.

  The Annals of pharmacotherapy 20021001

• Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine.

  Journal of clinical psychopharmacology 20021001

• Open-label study of olanzapine in children with pervasive developmental disorder.

  Journal of clinical psychopharmacology 20021001

• Fluvoxamine augmentation of olanzapine in chronic schizophrenia: pharmacokinetic interactions and clinical effects.

  Journal of clinical psychopharmacology 20021001

• Combination of olanzapine and divalproex for agitation in individuals with profound mental retardation.

  Journal of clinical psychopharmacology 20021001

• Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot study.

  Journal of clinical psychopharmacology 20021001

• Norepinephrine in the treatment of olanzapine overdose.

  Anaesthesia 20021001

• Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.

  The American journal of psychiatry 20021001

• [The role of olanzapine in Parkinsonian dopaminergic psychosis].

  Revista de neurologia 20021001

• Using antipsychotics in elderly patients.

  The Practitioner 20021001

• The effects of novel antipsychotics on glucose and lipid levels.

  The Journal of clinical psychiatry 20021001

• Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.

  The Journal of clinical psychiatry 20021001

• Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.

  The Journal of clinical psychiatry 20021001

• Severe hypertriglyceridemia associated with olanzapine.

  The Journal of clinical psychiatry 20021001

• Dissolution profile, tolerability, and acceptability of the orally disintegrating olanzapine tablet in patients with schizophrenia.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20021001

• Olanzapine for the treatment of chronic refractory schizophrenia: a 12-month follow-up naturalistic study.

  Progress in neuro-psychopharmacology & biological psychiatry 20021001

• Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patients.

  Progress in neuro-psychopharmacology & biological psychiatry 20021001

• Use of atypical antipsychotics in a Veterans Affairs hospital.

  Progress in neuro-psychopharmacology & biological psychiatry 20021001

• Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders.

  Bipolar disorders 20021001

• Studies of muscarinic receptor subtypes in salivary gland function in anaesthetized rats.

  Autonomic neuroscience : basic & clinical 20020930

• Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status.

  International clinical psychopharmacology 20020901

• From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications.

  The American journal of psychiatry 20020901

• Ziprasidone alternative for olanzapine-induced hyperglycemia.

  The American journal of psychiatry 20020901

• Olanzapine in the treatment of anorexia nervosa: an open label trial.

  The International journal of eating disorders 20020901

• [Improvement of tardive dyskinesia after treatment with olanzapine].

  Psychiatrische Praxis 20020901

• [Olanzapine-induced diabetes mellitus].

  Psychiatrische Praxis 20020901

• Continuum of care: stabilizing the acutely agitated patient.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020901

• Clinical issues associated with maintenance treatment of patients with schizophrenia.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020901

• Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine.

  Journal of psychopharmacology (Oxford, England) 20020901

• Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease.

  Biological psychiatry 20020901

• Olanzapine-induced hyperventilation: case report.

  Journal of psychiatry & neuroscience : JPN 20020901

• Atypical antipsychotics: experience and use in the elderly.

  International journal of clinical practice 20020901

• Comparative distribution of binding of the muscarinic receptor ligands pirenzepine, AF-DX 384, (R,R)-I-QNB and (R,S)-I-QNB to human brain.

  Journal of chemical neuroanatomy 20020901

• Olanzapine: a proarrhythmic drug?

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20020901

• Olanzapine treatment for dopaminergic-induced hallucinations.

  Movement disorders : official journal of the Movement Disorder Society 20020901

• Olanzapine excretion in human breast milk: estimation of infant exposure.

  The international journal of neuropsychopharmacology 20020901

• Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment.

  European psychiatry : the journal of the Association of European Psychiatrists 20020901

• [Olanzapine improves chorea in patients with Huntington's disease].

  Revista de neurologia 20020901

• [Zyprexa (olanzapine)--new possibilities in the treatment of schizophrenia].

  Voenno-meditsinskii zhurnal 20020901

• Presynaptic muscarinic receptor mechanisms and submandibular responses to stimulation of the parasympathetic innervation in bursts in rats.

  Autonomic neuroscience : basic & clinical 20020830

• Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder.

  Psychiatry research 20020805

• [Treatment of tics in Tourette syndrome with atypical antipsychotic drugs].

  Ugeskrift for laeger 20020805

• Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study.

  BMJ (Clinical research ed.) 20020803

• Excessive recruitment of neural systems subserving logical reasoning in schizophrenia.

  Brain : a journal of neurology 20020801

• Free and glucuronidated olanzapine serum concentrations in psychiatric patients: influence of carbamazepine comedication.

  Therapeutic drug monitoring 20020801

• Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting.

  Therapeutic drug monitoring 20020801

• Lethal catatonia.

  The Australian and New Zealand journal of psychiatry 20020801

• Emergence of compulsive symptoms with olanzapine treatment.

  The Australian and New Zealand journal of psychiatry 20020801

• Influence of ritonavir on olanzapine pharmacokinetics in healthy volunteers.

  Journal of clinical psychopharmacology 20020801

• Weight loss associated with olanzapine treatment.

  Journal of clinical psychopharmacology 20020801

• Rapid onset of tardive dyskinesia in Huntington disease with olanzapine.

  Journal of clinical psychopharmacology 20020801

• Restless legs syndrome and periodic limb movements of sleep: global therapeutic considerations.

  Sleep medicine reviews 20020801

• Management of symptoms associated with advanced cancer: olanzapine and mirtazapine. A World Health Organization project.

  Expert review of anticancer therapy 20020801

• Economic evaluations of olanzapine and risperidone.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020715

• Attenuation of the amphetamine discriminative cue in rats with the atypical antipsychotic olanzapine.

  Pharmacology, biochemistry, and behavior 20020701

• Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020701

• Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine.

  Schizophrenia research 20020701

• Extreme weight gain in a youth with schizophrenia: risk/benefit considerations.

  Schizophrenia research 20020701

• Olanzapine-associated type 2 diabetes mellitus.

  Schizophrenia research 20020701

• Service use and costs among VA patients with schizophrenia taking risperidone or olanzapine.

  Psychiatric services (Washington, D.C.) 20020701

• One-year rehospitalization rates of patients discharged on atypical versus conventional antipsychotics.

  Psychiatric services (Washington, D.C.) 20020701

• Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats.

  Journal of neural transmission (Vienna, Austria : 1996) 20020701

• Atypical neuroleptics stimulate neurogenesis in adult rat brain.

  Journal of neuroscience research 20020701

• Olanzapine-associated diabetes mellitus.

  Pharmacotherapy 20020701

• Effect of a single-dose of olanzapine on sleep in healthy females and males.

  International clinical psychopharmacology 20020701

• Fatality from olanzapine induced hyperglycemia.

  Journal of forensic sciences 20020701

• Switching to olanzapine from previous antipsychotics: a regional collaborative multicenter trial assessing 2 switching techniques in Asia Pacific.

  The Journal of clinical psychiatry 20020701

• Olanzapine for cocaine craving and relapse prevention in 2 patients.

  The Journal of clinical psychiatry 20020701

• Sleep-related eating disorder induced by olanzapine.

  The Journal of clinical psychiatry 20020701

• The value of atypical antipsychotics in the treatment of schizophrenia.

  Managed care (Langhorne, Pa.) 20020701

• Coexistence of Capgras and Frégoli syndromes in a single patient. Clinical, neuroimaging and neuropsychological findings.

  European psychiatry : the journal of the Association of European Psychiatrists 20020701

• Glucuronidation of olanzapine by cDNA-expressed human UDP-glucuronosyltransferases and human liver microsomes.

  Human psychopharmacology 20020701

• Olanzapine improves social dysfunction in cluster B personality disorder.

  Human psychopharmacology 20020701

• Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia.

  The International journal of neuroscience 20020701

• Determination of olanzapine in plasma by high-performance liquid chromatography using ultraviolet absorbance detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020625

• Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain.

  Neuroscience letters 20020607

• Effect of olanzapine on glutamate levels in cerebrospinal fluid of patients with schizophrenia.

  Journal of clinical psychopharmacology 20020601

• Olanzapine in Huntington's disease.

  Acta neurologica Scandinavica 20020601

• Prefrontal cortex acetylcholine release, EEG slow waves, and spindles are modulated by M2 autoreceptors in C57BL/6J mouse.

  Journal of neurophysiology 20020601

• Olanzapine versus divalproex in the treatment of acute mania.

  The American journal of psychiatry 20020601

• Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.

  The American journal of psychiatry 20020601

• Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.

  The American journal of psychiatry 20020601

• Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition.

  The American journal of psychiatry 20020601

• Quetiapine for olanzapine-induced galactorrhea.

  The American journal of psychiatry 20020601

• Atypical antipsychotics and cognition in schizophrenia.

  Archives of general psychiatry 20020601

• Efficacy of olanzapine and risperidone for treatment-refractory schizophrenia among long-stay state hospital patients.

  Psychiatric services (Washington, D.C.) 20020601

• Y-931, a novel atypical antipsychotic drug, is less sensitive to oxidative phenomena.

  Chemical & pharmaceutical bulletin 20020601

• Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo.

  The Journal of clinical endocrinology and metabolism 20020601

• Uses of olanzapine.

  The Australian and New Zealand journal of psychiatry 20020601

• Ecstasy-induced psychotic disorder: six-month follow-up study.

  European addiction research 20020601

• A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain.

  Journal of pain and symptom management 20020601

• A possible association between high normal and high dose olanzapine and prolongation of the PR interval.

  Journal of psychopharmacology (Oxford, England) 20020601

• Influence of fluoxetine on olanzapine pharmacokinetics.

  AAPS pharmSci 20020601

• A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia.

  Psychopharmacology 20020601

• Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorder.

  Psychopharmacology 20020601

• Clozapine is more efficacious for tongue dystonia than olanzapine.

  Psychopharmacology 20020601

• Olanzapine-induced galactorrhea.

  Psychopharmacology 20020601

• Olanzapine in the treatment of refractory migraine and chronic daily headache.

  Headache 20020601

• Effect of prenatal administration of haloperidol, risperidone, quetiapine and olanzapine on spatial learning and retention in adult rats.

  Pharmacology, biochemistry, and behavior 20020601

• Efficacy of electroconvulsive therapy combined with antipsychotic medication in treatment-resistant schizophrenia: a prospective, open trial.

  The journal of ECT 20020601

• ECT treatment of malignant catatonia/NMS in an adolescent: a useful lesson in delayed diagnosis and treatment.

  The journal of ECT 20020601

• Olanzapine-associated neuroleptic malignant syndrome.

  Progress in neuro-psychopharmacology & biological psychiatry 20020601

• A clinical case series of six extremely aggressive youths treated with olanzapine.

  European child & adolescent psychiatry 20020601

• In vitro P-glycoprotein affinity for atypical and conventional antipsychotics.

  Life sciences 20020531

• Sex differences in clinical response to olanzapine compared with haloperidol.

  Psychiatry research 20020515

• Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020501

• Clinical and neuropsychological correlates of the P300 in schizophrenia.

  Schizophrenia research 20020501

• Muscarinic receptor knockout mice: role of muscarinic acetylcholine receptors M(2), M(3), and M(4) in carbamylcholine-induced gallbladder contractility.

  The Journal of pharmacology and experimental therapeutics 20020501

• Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine.

  International clinical psychopharmacology 20020501

• A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.

  Archives of general psychiatry 20020501

• Atypical neuroleptic malignant syndrome associated with olanzapine.

  Pharmacotherapy 20020501

• Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study.

  The Journal of clinical psychiatry 20020501

• Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.

  The Journal of clinical psychiatry 20020501

• A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year.

  The Journal of clinical psychiatry 20020501

• Phencyclidine supersensitivity in rats with neonatal dopamine loss.

  Psychopharmacology 20020501

• Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions.

  Psychopharmacology 20020501

• Tardive dyskinesias and antipsychotics: a review.

  European psychiatry : the journal of the Association of European Psychiatrists 20020501

• Olanzapine-induced mania in bipolar disorders.

  Journal of psychiatry & neuroscience : JPN 20020501

• Clinical and economic outcomes associated with olanzapine for the treatment of psychotic symptoms in a county mental health population.

  Clinical therapeutics 20020501

• Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trial.

  Journal of affective disorders 20020501

• Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine?

  Pharmacopsychiatry 20020501

• Olanzapine and pregnancy.

  Pharmacopsychiatry 20020501

• Decrease of energy expenditure causes weight increase in olanzapine treatment - a case study.

  Pharmacopsychiatry 20020501

• Olanzapine and progesterone have dose-dependent and additive effects to enhance lordosis and progestin concentrations of rats.

  Physiology & behavior 20020501

• Improvement of tardive dyskinesia following switch from neuroleptics to olanzapine.

  Progress in neuro-psychopharmacology & biological psychiatry 20020501

• Decreased density of [3H]TCP binding following antipsychotic drug withdrawal in rats.

  Life sciences 20020419

• Acetylcholine-induced contractions in the perforating branch of the human internal mammary artery: protective role of the vascular endothelium.

  Pharmacology 20020401

• The nature of the acetylcholine and 5-hydroxytryptamine receptors in buccal smooth muscle of the pest slug Deroceras reticulatum.

  Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology 20020401

• Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.

  The American journal of psychiatry 20020401

• Serotonin syndrome and atypical antipsychotics.

  The American journal of psychiatry 20020401

• Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020401

• [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].

  Fortschritte der Neurologie-Psychiatrie 20020401

• Weight gain and hyperglycaemia associated with olanzapine.

  The Australian and New Zealand journal of psychiatry 20020401

• Effects of atypical antipsychotics on vertebrate neuromuscular transmission.

  Neuropharmacology 20020401

• Lewy body dementia.

  Journal of the Mississippi State Medical Association 20020401

• Olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome: case report.

  International journal of geriatric psychiatry 20020401

• Olanzapine in the management of cancer pain.

  Journal of pain and symptom management 20020401

• Motor-induced brain activation in cortical, subcortical and cerebellar regions in schizophrenic inpatients. A whole brain fMRI fingertapping study.

  Progress in neuro-psychopharmacology & biological psychiatry 20020401

• The use of concomitant medications in psychiatric inpatients treated with either olanzapine or other antipsychotic agents: a naturalistic study at a state psychiatric hospital.

  Progress in neuro-psychopharmacology & biological psychiatry 20020401

• [Delusional ectoparasitic infestation in multiple system atrophy].

  Der Nervenarzt 20020401

• Activation of nitric oxide synthase through muscarinic receptors in rat parotid gland.

  European journal of pharmacology 20020329

• Muscarinic cholinergic receptor subtypes in the hippocampus of aged rats.

  Mechanisms of ageing and development 20020315

• Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine.

  Biological psychiatry 20020315

• Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020301

• Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia.

  The American journal of psychiatry 20020301

• Olanzapine for violent schizophrenia and Klinefelter syndrome.

  The American journal of psychiatry 20020301

• Effects of antipsychotic drugs on operant responding after acute and repeated administration.

  Psychopharmacology 20020301

• [Atypical neuroleptics in the treatment of aggression and hostility in schizophrenic patients].

  Fortschritte der Neurologie-Psychiatrie 20020301

• Riluzole and olanzapine in Huntington's disease.

  European journal of neurology 20020301

• Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study.

  Journal of the American Academy of Child and Adolescent Psychiatry 20020301

• Implicit and explicit learning in schizophrenics treated with olanzapine and with classic neuroleptics.

  Psychopharmacology 20020301

• Time to study discontinuation, relapse, and compliance with atypical or conventional antipsychotics in schizophrenia and related disorders.

  International clinical psychopharmacology 20020301

• Olanzapine augmentation in the treatment of melancholia: the trajectory of improvement in rapid responders.

  International clinical psychopharmacology 20020301

• High-dose olanzapine in Huntington's disease.

  International clinical psychopharmacology 20020301

• New-onset seizure associated with quetiapine and olanzapine.

  The Annals of pharmacotherapy 20020301

• New treatments in cluster headache.

  Current neurology and neuroscience reports 20020301

• Eosinophilia associated with olanzapine.

  The Journal of clinical psychiatry 20020301

• Olanzapine-induced destabilization of diabetes in the absence of weight gain.

  Acta psychiatrica Scandinavica 20020301

• The atypical antipsychotic olanzapine enhances ingestive behaviour in the rat: a preliminary study.

  Journal of psychopharmacology (Oxford, England) 20020301

• Chronic treatments with tacrine and (-)-nicotine induce different changes of nicotinic and muscarinic acetylcholine receptors in the brain of aged rat.

  Journal of neural transmission (Vienna, Austria : 1996) 20020301

• [The effects of the antagonists of muscarinic acetylcholine receptor subtypes in rat brain on urinary bladder contraction].

  Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20020301

• Muscarinic modulation of hypoxia-induced release of catecholamines from the cat carotid body.

  Brain research 20020215

• Determination of olanzapine in human blood by liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020205

• Are the atypical antipsychotic drugs antidepressants?

  Journal of clinical psychopharmacology 20020201

• Olanzapine-induced agranulocytosis: a case report and review of the literature.

  Progress in neuro-psychopharmacology & biological psychiatry 20020201

• Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.

  The American journal of psychiatry 20020201

• Use of dreams by psychopharmacologists.

  The American journal of psychiatry 20020201

• Olanzapine in acute bipolar mania.

  Archives of general psychiatry 20020201

• Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.

  The Journal of clinical psychiatry 20020201

• Olanzapine for the treatment of monosymptomatic hypochondriacal psychosis.

  The Journal of clinical psychiatry 20020201

• A retrospective economic evaluation of olanzapine versus risperidone in the treatment of schizophrenia.

  Managed care interface 20020201

• Subcortical overactivation in untreated schizophrenic patients: a functional magnetic resonance image finger-tapping study.

  Psychiatry and clinical neurosciences 20020201

• The impact of response to previous mood stabilizer therapy on response to olanzapine versus placebo for acute mania.

  Bipolar disorders 20020201

• Apraxia of eyelid closure in Huntington's disease.

  Journal of neural transmission (Vienna, Austria : 1996) 20020201

• Acute administration of antipsychotics modulates Homer striatal gene expression differentially.

  Brain research. Molecular brain research 20020131

• [Drug-induced akathisia].

  Nederlands tijdschrift voor geneeskunde 20020119

• Muscarinic receptor subtypes mediate stimulatory and paradoxical inhibitory effects on an insulin-secreting beta cell line.

  Biochimica et biophysica acta 20020115

• Coupling of M(2) muscarinic receptors to Src activation in cultured canine colonic smooth muscle cells.

  American journal of physiology. Gastrointestinal and liver physiology 20020101

• Estrogen effects on object memory and cholinergic receptors in young and old female mice.

  Neurobiology of aging 20020101

• Elevation of prolactin levels by atypical antipsychotics.

  The American journal of psychiatry 20020101

• Increasing insulin dose for olanzapine-related diabetes.

  The American journal of psychiatry 20020101

• Fluoxetine and olanzapine for resistant depression.

  The American journal of psychiatry 20020101

• Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

  Archives of general psychiatry 20020101

• A correction.

  Archives of general psychiatry 20020101

• Comparison of risperidone with olanzapine in elderly patients with dementia and psychosis.

  Pharmacotherapy 20020101

• Relationship between neuroleptic dosage and subjective cognitive dysfunction in schizophrenic patients treated with either conventional or atypical neuroleptic medication.

  International clinical psychopharmacology 20020101

• Hypotension and bradycardia in a healthy volunteer following a single 5 mg dose of olanzapine.

  Journal of clinical pharmacology 20020101

• Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol.

  Pharmacology, biochemistry, and behavior 20020101

• The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteers.

  Clinical pharmacology and therapeutics 20020101

• [Usefulness of olanzapine in the levodopa-induced psychosis in patients with Parkinson's disease].

  Neurologia (Barcelona, Spain) 20020101

• Hyperinsulinemia in psychiatric patients treated with olanzapine.

  The Journal of clinical psychiatry 20020101

• Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies.

  Dementia and geriatric cognitive disorders 20020101

• Pirenzepine affects scleral metabolic changes in myopia through a non-toxic mechanism.

  Experimental eye research 20020101

• Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial.

  Journal of psychiatric research 20020101

• The role of novel antipsychotics in bipolar disorders.

  The Journal of clinical psychiatry 20020101

• Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited.

  The Journal of clinical psychiatry 20020101

• Movement disorders associated with atypical antipsychotic drugs.

  The Journal of clinical psychiatry 20020101

• Significant dissociation of brain and plasma kinetics with antipsychotics.

  Molecular psychiatry 20020101

• Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine.

  Psychosomatics 20020101

• Psychiatric symptoms in a case of intracranial tuberculosis.

  Psychosomatics 20020101

• [Gastrozepin therapy of gallbladder motility disorders in patients with ischemic heart disease].

  Likars'ka sprava 20020101

• Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents.

  CNS drugs 20020101

• Treatment of patients with tardive dystonia with olanzapine.

  Clinical neuropharmacology 20020101

• The efficacy of olanzapine, as needed, to treat acute agitation in juveniles.

  Journal of child and adolescent psychopharmacology 20020101

• Refractory obsessive-compulsive disorder: state-of-the-art treatment.

  The Journal of clinical psychiatry 20020101

• Cardiovascular effects of novel antipsychotic medications.

  Heart disease (Hagerstown, Md.) 20020101

• [Olanzapine in Tourette's syndrome: a report of three cases].

  Actas espanolas de psiquiatria 20020101

• [The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• Antipsychotic prescribing practices in the Veterans Healthcare Administration--New York metropolitan region.

  Schizophrenia bulletin 20020101

• Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.

  The West Virginia medical journal 20020101

• The role of atypical antipsychotics in the treatment of delirium.

  Psychosomatics 20020101

• An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients.

  Psychosomatics 20020101

• Masturbatory guilt leading to severe depression and erectile dysfunction.

  Journal of sex & marital therapy 20020101

• Comment: risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine.

  The Annals of pharmacotherapy 20020101

• Direct-injection high performance liquid chromatography ion trap mass spectrometry for the quantitative determination of olanzapine, clozapine and N-desmethylclozapine in human plasma.

  Rapid communications in mass spectrometry : RCM 20020101

• Marked improvement of Meige's syndrome with olanzapine in a schizophrenic patient.

  The Journal of neuropsychiatry and clinical neurosciences 20020101

• Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine.

  Journal of child and adolescent psychopharmacology 20020101

• Near fatal ketoacidosis with olanzapine treatment.

  Psychosomatics 20020101

• [Zyprexa with superior effectiveness-risk relation. For every therapy situation a suitable dosage form].

  Krankenpflege Journal 20020101

• [Muscarinic receptors of the neostriatum -- important targets of regulation of instrumental movement and posture].

  Aviakosmicheskaia i ekologicheskaia meditsina = Aerospace and environmental medicine 20020101

• Atypical antipsychotics in Parkinson-sensitive populations.

  Journal of geriatric psychiatry and neurology 20020101

• Olanzapine-induced EDTA-dependent pseudothrombocytopenia.

  Psychosomatics 20020101

• [Influence of serotonergic transmission on response to olanzapine].

  Actas espanolas de psiquiatria 20020101

• Olanzapine for Huntington's disease: an open label study.

  Clinical neuropharmacology 20020101

• Effects of olanzapine and clozapine upon pulse rate variability.

  Depression and anxiety 20020101

• Differential effects of olanzapine and risperidone on cognition in schizophrenia? A saccadic eye movement study.

  The Journal of neuropsychiatry and clinical neurosciences 20020101

• A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months.

  Current medical research and opinion 20020101

• Olanzapine treatment of corticosteroid-induced mood disorders.

  Psychosomatics 20020101

• Olanzapine and neuroleptic malignant syndrome.

  Psychosomatics 20020101

• Glucose intolerance with atypical antipsychotics.

  Drug safety 20020101

• Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia.

  Molecular psychiatry 20020101

• Adverse drug reaction update.

  Adverse drug reactions and toxicological reviews 20020101

• A cost-effectiveness clinical decision analysis model for treatment of Schizophrenia.

  Archives of medical research 20020101

• [Schizoaffective disorder: clinical symptoms and present-day approach to treatment].

  Medicina (Kaunas, Lithuania) 20020101

• [RODOS: risperidone olanzapine drug outcome studies in schizophrenia].

  L'Encephale 20020101

• Olanzapine overdose: a pediatric case report.

  Journal of child and adolescent psychopharmacology 20020101

• [Olanzapine in the first episode of schizophrenia in young adults].

  Psychiatria polska 20020101

• Comparing the side effect profile of the atypical antipsychotics.

  West African journal of medicine 20020101

• [Effect of olanzapine treatment on cognitive functions in patients with schizophrenia].

  Psychiatria polska 20020101

• [Subjective and objective assessment of memory functions in patients with schizophrenia treated with olanzapine].

  Psychiatria polska 20020101

• Cost-effectiveness of risperidone, olanzapine, and conventional antipsychotic medications.

  Schizophrenia bulletin 20020101

• M2 muscarinic autoreceptors modulate acetylcholine release in prefrontal cortex of C57BL/6J mouse.

  The Journal of pharmacology and experimental therapeutics 20011201

• Olanzapine-induced priapism.

  The American journal of psychiatry 20011201

• Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.

  Biological psychiatry 20011201

• Broad therapeutic uses of atypical antipsychotic medications.

  Biological psychiatry 20011201

• The central cholinergic system profile of olanzapine compared with placebo in Alzheimer's disease.

  International journal of geriatric psychiatry 20011201

• A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data.

  International journal of geriatric psychiatry 20011201

• Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia.

  International journal of geriatric psychiatry 20011201

• Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis.

  International journal of geriatric psychiatry 20011201

• The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia.

  Journal of clinical psychopharmacology 20011201

• Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double-blind, placebo-controlled, cross-over study.

  Journal of clinical psychopharmacology 20011201

• The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England.

  Journal of psychopharmacology (Oxford, England) 20011201

• Lethal catatonia responding to high-dose olanzapine therapy.

  Journal of psychopharmacology (Oxford, England) 20011201

• Olanzapine treatment for patients with schizophrenia and substance abuse.

  Journal of substance abuse treatment 20011201

• Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.

  The Journal of clinical psychiatry 20011201

• Olanzapine, new-onset diabetes mellitus, and risk for insulin overdose.

  The Journal of clinical psychiatry 20011201

• [Heart rate variability in schizophrenic patients treated with antipsychotic agents].

  Harefuah 20011201

• Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine.

  The Annals of pharmacotherapy 20011201

• Olanzapine-induced diabetic ketoacidosis.

  The Annals of pharmacotherapy 20011201

• Olanzapine versus haloperidol in schizoaffective disorder, bipolar type.

  Journal of affective disorders 20011201

• Use of olanzapine for elderly patients with psychotic disorders: a review.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20011201

• Olanzapine and pregnancy.

  The Australian and New Zealand journal of psychiatry 20011201

• Atypical antipsychotic drugs and hyperglycemia in adolescents.

  JAMA 20011128

• Selective nucleation and discovery of organic polymorphs through epitaxy with single crystal substrates.

  Journal of the American Chemical Society 20011107

• Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine.

  European journal of pharmacology 20011102

• Global index of safety (GIS): a new instrument to assess drug safety.

  Journal of clinical epidemiology 20011101

• Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.

  Psychiatric services (Washington, D.C.) 20011101

• Conclusions about risperidone.

  Psychiatric services (Washington, D.C.) 20011101

• Olanzapine augmentation for trichotillomania.

  The American journal of psychiatry 20011101

• [Olanzapine: pharmacology, pharmacokinetics and therapeutic drug monitoring].

  Fortschritte der Neurologie-Psychiatrie 20011101

• Olanzapine treatment for post-traumatic stress disorder: an open-label study.

  International clinical psychopharmacology 20011101

• Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine.

  Psychopharmacology 20011101

• Dramatic worsening of type 2 diabetes mellitus due to olanzapine after 3 years of therapy.

  Pharmacotherapy 20011101

• Olanzapine-associated severe hyperglycemia, ketonuria, and acidosis: case report and review of literature.

  Pharmacotherapy 20011101

• [Olanzapine and pregnancy. 2 case reports].

  Der Nervenarzt 20011101

• Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study.

  The Journal of clinical psychiatry 20011101

• Body weight gain, insulin, and leptin in olanzapine-treated patients.

  The Journal of clinical psychiatry 20011101

• [Clinical and pharmacological studies of the second generation antipsychotics].

  Fukuoka igaku zasshi = Hukuoka acta medica 20011101

• Receptor reserve of phosphoinositide-coupled muscarinic receptors in mouse hippocampus in vivo.

  Brain research 20011019

• On the functional role of muscarinic M2 receptors in cholinergic and purinergic responses in the rat urinary bladder.

  European journal of pharmacology 20011012

• Atypical antipsychotics: impaired glucose metabolism.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20011002

• An open pilot trial of olanzapine for delirium in the Korean population.

  Psychiatry and clinical neurosciences 20011001

• The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011001

• Characterization of muscarinic acetylcholine receptors in the rat epididymis.

  Biology of reproduction 20011001

• Use of olanzapine in dysphoric mania.

  Journal of affective disorders 20011001

• Association of olanzapine-induced weight gain with an increase in body fat.

  The American journal of psychiatry 20011001

• Agranulocytosis and neutropenia with typical and atypical neuroleptics.

  The American journal of psychiatry 20011001

• Addition of olanzapine for treatment-resistant depression.

  The American journal of psychiatry 20011001

• Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder.

  Journal of clinical psychopharmacology 20011001

• Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity.

  Biological psychiatry 20011001

• Autonomic responses of blood vessels and sweat glands in patients with schizophrenia treated with olanzapine or clozapine.

  Psychopharmacology 20011001

• Olanzapine in pregnancy.

  The Annals of pharmacotherapy 20011001

• P300 and symptom improvement in schizophrenia.

  Psychopharmacology 20011001

• Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20011001

• [Efficacy of rispolept and zyprexa in the treatment of patients with schizophrenia].

  Voenno-meditsinskii zhurnal 20011001

• [Diabetes mellitus induced by olanzapine. A case report].

  Revista medica de Chile 20011001

• Beneficial effect of muscarinic-2 antagonist on dilated cardiomyopathy induced by autoimmune mechanism against muscarinic-2 receptor.

  Journal of cardiovascular pharmacology 20011001

• Service use and costs of treating schizophrenia with atypical antipsychotics.

  The Journal of clinical psychiatry 20011001

• Olanzapine versus other antipsychotics in the treatment of schizophrenia.

  The Journal of clinical psychiatry 20011001

• [Importance of blood glucose level when starting antipsychotic treatment].

  Presse medicale (Paris, France : 1983) 20010922

• Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze.

  European journal of pharmacology 20010907

• Integration of olanzapine determinations in a HPLC-diode array detection system for routine psychotropic drug monitoring.

  Clinical chemistry 20010901

• Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the food and drug administration database.

  The American journal of psychiatry 20010901

• Muscarinic activation of inwardly rectifying K(+) conductance reduces EPSPs in rat hippocampal CA1 pyramidal cells.

  The Journal of physiology 20010901

• Tissue distribution of olanzapine in a postmortem case.

  The American journal of forensic medicine and pathology 20010901

• D2 receptor occupancy under recommended and high doses of olanzapine.

  Journal of psychopharmacology (Oxford, England) 20010901

• [Incompatibility of olanzapine and amisulpride in multisystemic myotonic myopathy].

  Der Nervenarzt 20010901

• Olanzapine-induced rhabdomyolysis.

  The Annals of pharmacotherapy 20010901

• Olanzapine as an abortive agent for cluster headache.

  Headache 20010901

• Re: Weight change with antipsychotic use.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010901

• Olanzapine induces remarkable weight gain in adolescent patients.

  European child & adolescent psychiatry 20010901

• Are African American patients at a higher risk for olanzapine-induced glucose intolerance?

  Psychopharmacology 20010901

• The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia.

  The international journal of neuropsychopharmacology 20010901

• Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.

  The Journal of clinical psychiatry 20010901

• Treatment of preexisting diabetes with olanzapine.

  The Journal of clinical psychiatry 20010901

• Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.

  European journal of clinical pharmacology 20010901

• An open trial of olanzapine in the treatment of patients with psychotic depression.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20010901

• Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients.

  Neurology 20010828

• Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients.

  Neurology 20010828

• Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.

  Psychiatry research 20010825

• Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile.

  European journal of pharmacology 20010817

• A high-performance liquid chromatography assay with ultraviolet detection for olanzapine in human plasma and urine.

  Journal of chromatography. B, Biomedical sciences and applications 20010815

• Inhibition of myopia development in chicks using himbacine: a role for M(4) receptors?

  Neuroreport 20010808

• Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography.

  Journal of chromatography. B, Biomedical sciences and applications 20010805

• Extended treatment with typical and atypical antipsychotic drugs differential effects on the densities of dopamine D2-like and GABAA receptors in rat striatum.

  Life sciences 20010803

• Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients.

  Psychoneuroendocrinology 20010801

• Effect of olanzapine on functional responses from sensitized D1-dopamine receptors in rats with neonatal dopamine loss.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010801

• Efficacy and safety of olanzapine, an atypical antipsychotic, in patients with schizophrenia: results of an open-label multicenter study in Japan.

  Psychiatry and clinical neurosciences 20010801

• Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: results of the Japan multicenter, double-blind olanzapine trial.

  Psychiatry and clinical neurosciences 20010801

• Novel antipsychotics and severe hyperlipidemia.

  Journal of clinical psychopharmacology 20010801

• Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America.

  Journal of clinical psychopharmacology 20010801

• A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania.

  Journal of clinical psychopharmacology 20010801

• Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial.

  Journal of clinical psychopharmacology 20010801

• Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: evidence from a therapeutic drug monitoring service.

  Therapeutic drug monitoring 20010801

• Instability of olanzapine in calf serum.

  Therapeutic drug monitoring 20010801

• Olanzapine for the treatment of fibromyalgia symptoms.

  Journal of pain and symptom management 20010801

• Mirtazapine for excessive masturbation in an adolescent with autism.

  Journal of the American Academy of Child and Adolescent Psychiatry 20010801

• Olanzapine versus haloperidol in children with autistic disorder: an open pilot study.

  Journal of the American Academy of Child and Adolescent Psychiatry 20010801

• Effects of olanzapine on cerebellar functional connectivity in schizophrenia measured by fMRI during a simple motor task.

  Psychological medicine 20010801

• Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.

  Molecular and cellular neurosciences 20010801

• Muscarinic receptors control K+ secretion in inner ear strial marginal cells.

  The Journal of membrane biology 20010801

• Tardive dystonia associated with olanzapine therapy.

  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20010801

• Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats.

  Biological psychiatry 20010715

• Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.

  The American journal of psychiatry 20010701

• Olanzapine-induced somnambulism.

  The American journal of psychiatry 20010701

• A program for treating olanzapine-related weight gain.

  Psychiatric services (Washington, D.C.) 20010701

• Continuing treatment with novel antipsychotic drugs despite leukopenia or thrombocytopenia.

  Archives of general psychiatry 20010701

• Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study.

  International clinical psychopharmacology 20010701

• Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): health economic results of an international naturalistic study.

  International clinical psychopharmacology 20010701

• Olanzapine in the treatment of post-traumatic stress disorder: a pilot study.

  International clinical psychopharmacology 20010701

• Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.

  The Journal of clinical psychiatry 20010701

• Maternal obesity and risk of neural tube defects.

  Canadian family physician Medecin de famille canadien 20010701

• Effects of acute versus chronic treatment with typical or atypical antipsychotics on d-amphetamine-induced sensorimotor gating deficits in rats.

  Psychopharmacology 20010701

• Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats.

  Psychopharmacology 20010701

• Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation.

  Psychopharmacology 20010701

• Use of atypical antipsychotics in mood disorders.

  Current opinion in investigational drugs (London, England : 2000) 20010701

• Olanzapine for psychosis in Parkinson's disease.

  Neurology 20010626

• Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment.

  The American journal of psychiatry 20010601

• Cognitive behavior therapy for weight gain.

  The American journal of psychiatry 20010601

• Improvement of hallucinogen persisting perception disorder by treatment with a combination of fluoxetine and olanzapine: case report.

  Journal of clinical psychopharmacology 20010601

• Hyperglycemia in patients with schizophrenia who are treated with olanzapine.

  Journal of clinical psychopharmacology 20010601

• Antiaggressive action of atypical antipsychotics in patients with schizophrenia.

  Journal of clinical psychopharmacology 20010601

• Diabetic ketoacidosis associated with olanzapine in an adolescent patient.

  The Journal of pediatrics 20010601

• Tardive dyskinesia caused by the atypical antipsychotic risperidone and cured by the use of another drug of the same class, olanzapine.

  European psychiatry : the journal of the Association of European Psychiatrists 20010601

• Effects of cholinergic agents on the vasopressin-mediated water transport in the isolated toad bladder.

  Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20010601

• Effects of omeprazole and pirenzepine on enterochromaffin-like cells and parietal cells in rat stomach.

  Journal of gastroenterology 20010601

• Does pirenzepine suppress the undesirable effects of a proton pump inhibitor on enterochromaffin-like cells?

  Journal of gastroenterology 20010601

• The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophrenia.

  The Journal of nervous and mental disease 20010601

• Acute severe catatonia in a young woman with chronic schizophrenia responding to parenteral clonazepam.

  The Australian and New Zealand journal of psychiatry 20010601

• Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: evaluating the indirect approach.

  Clinical therapeutics 20010601

• Olanzapine-related hyperglycemia in a nondiabetic woman.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010601

• Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine.

  Journal of psychopharmacology (Oxford, England) 20010601

• Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study.

  Psychopharmacology 20010601

• Effectiveness of clozapine and olanzapine: a comparison in severe, psychotically ill patients.

  The international journal of neuropsychopharmacology 20010601

• Olanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases.

  European child & adolescent psychiatry 20010601

• Involvement of the cholinergic pathway in the pathogenesis of pituitary Cushing's syndrome.

  Endocrine journal 20010601

• Ziprasidone: a new atypical antipsychotic.

  Expert opinion on pharmacotherapy 20010601

• Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.

  European archives of psychiatry and clinical neuroscience 20010601

• Antibodies against human putamen in adolescents with anorexia nervosa.

  The International journal of eating disorders 20010501

• Agonist activation of cytosolic Ca2+ in subfornical organ cells projecting to the supraoptic nucleus.

  American journal of physiology. Regulatory, integrative and comparative physiology 20010501

• Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.

  The Journal of pharmacology and experimental therapeutics 20010501

• Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity.

  The Journal of pharmacology and experimental therapeutics 20010501

• Nitric oxide modulates cardiac performance in the heart of Anguilla anguilla.

  The Journal of experimental biology 20010501

• A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.

  The American journal of psychiatry 20010501

• Olanzapine and negative and positive symptoms.

  The American journal of psychiatry 20010501

• Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine.

  Psychiatric services (Washington, D.C.) 20010501

• Olanzapine-induced diabetes mellitus.

  The Annals of pharmacotherapy 20010501

• Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010501

• Interaction of olanzapine with fluvoxamine.

  Psychopharmacology 20010501

• Priapism associated with conventional and atypical antipsychotic medications: a review.

  The Journal of clinical psychiatry 20010501

• Writer's cramp induced by olanzapine.

  Journal of neurology 20010501

• [Analysis of olanzapine in human plasma with reversed-phase high performance liquid chromatography].

  Se pu = Chinese journal of chromatography 20010501

• Ligand characterization using microphysiometry.

  Current protocols in neuroscience 20010501

• Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone.

  Schizophrenia research 20010430

• Functional characterization of rat submaxillary gland muscarinic receptors using microphysiometry.

  British journal of pharmacology 20010401

• Olanzapine and Huntington's disease.

  Journal of clinical psychopharmacology 20010401

• Reply to comments on 'Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study'.

  Journal of clinical psychopharmacology 20010401

• Olanzapine-associated priapism.

  Journal of clinical psychopharmacology 20010401

• Six-month outcomes for patients who switched to olanzapine treatment.

  Psychiatric services (Washington, D.C.) 20010401

• Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic.

  The American journal of psychiatry 20010401

• Ondansetron for tardive dyskinesia.

  The American journal of psychiatry 20010401

• Olanzapine overdose.

  Anaesthesia 20010401

• Comment: olanzapine-induced acute pancreatitis.

  The Annals of pharmacotherapy 20010401

• Manic symptoms induced by olanzapine.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20010401

• Effect of amantadine on weight gain during olanzapine treatment.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20010401

• Anticholinergic treatment improves glycaemic control in adolescent girls with insulin-dependent diabetes mellitus.

  Acta paediatrica (Oslo, Norway : 1992) 20010401

• Use of olanzapine in non-psychotic psychiatric disorders.

  Expert opinion on pharmacotherapy 20010401

• Effects of pirenzepine, omeprazole, lansoprazole, and rabeprazole on human neutrophil functions.

  Canadian journal of anaesthesia = Journal canadien d'anesthesie 20010401

• Atypical antipsychotic drugs: how much better are they?

  The Harvard mental health letter 20010401

• Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.

  The Journal of pharmacy and pharmacology 20010401

• Dopamine receptor responsivity in schizophrenic patients in a drug-free state and after treatment with olanzapine.

  Progress in neuro-psychopharmacology & biological psychiatry 20010401

• Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol.

  Psychopharmacology 20010401

• Infralimbic muscarinic M1 receptors modulate anxiety-like behaviour and spontaneous working memory in mice.

  Psychopharmacology 20010401

• Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.

  The Journal of clinical psychiatry 20010401

• Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.

  The Journal of clinical psychiatry 20010401

• An open-label study of the treatment efficacy of olanzapine for Tourette's disorder.

  The Journal of clinical psychiatry 20010401

• Low-dose olanzapine for self-mutilation behavior in patients with borderline personality disorder.

  The Journal of clinical psychiatry 20010401

• Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report.

  The Journal of clinical psychiatry 20010401

• Olanzapine in the treatment of tardive dyskinesia: a report of 2 cases.

  The Journal of clinical psychiatry 20010401

• [What does olanzapine give us?].

  Atencion primaria 20010331

• The allosteric interaction of otenzepad (AF-DX 116) at muscarinic M2 receptors in guinea pig atria.

  European journal of pharmacology 20010330

• Separation of olanzapine, carbamazepine and their main metabolites by capillary electrophoresis with pseudo-stationary phases.

  Journal of chromatography. B, Biomedical sciences and applications 20010305

• Quantitative determination of olanzapine in rat brain tissue by high-performance liquid chromatography with electrochemical detection.

  Journal of chromatography. B, Biomedical sciences and applications 20010305

• Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.

  The American journal of psychiatry 20010301

• Low blood glucose and olanzapine.

  The American journal of psychiatry 20010301

• Dose-dependent olanzapine-associated leukopenia: three case reports.

  International clinical psychopharmacology 20010301

• Atypical antipsychotics and hyperglycaemia.

  International clinical psychopharmacology 20010301

• 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.

  Journal of neurochemistry 20010301

• Olanzapine-lnduced hyperglycemic nonketonic coma.

  The Annals of pharmacotherapy 20010301

• Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study.

  Schizophrenia research 20010301

• Treatment of posttraumatic stress disorder with olanzapine.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010301

• Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants.

  Southern medical journal 20010301

• Dementia with Lewy bodies in Down's syndrome.

  International journal of geriatric psychiatry 20010301

• Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.

  The Journal of clinical psychiatry 20010301

• Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents.

  Psychopharmacology 20010301

• Blood pressure and heart rate are increased by AF-DX 116, a selective M2 antagonist, in autonomic imbalanced and hypotensive rats caused by repeated cold stress.

  Japanese journal of pharmacology 20010301

• Characterisation of the prejunctional inhibitory muscarinic receptor on cholinergic nerves in the rat urinary bladder.

  European journal of pharmacology 20010216

• Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics.

  The American journal of psychiatry 20010201

• Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder.

  Archives of general psychiatry 20010201

• Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways.

  Synapse (New York, N.Y.) 20010201

• Atypical antipsychotics and cardiovascular risk in schizophrenic patients.

  Journal of clinical psychopharmacology 20010201

• Repeated episodes of hypothermia in a subject treated with haloperidol, levomepromazine, olanzapine, and thioridazine.

  Journal of clinical psychopharmacology 20010201

• The economic consequences of a drug-drug interaction.

  Journal of clinical psychopharmacology 20010201

• Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial.

  Journal of clinical psychopharmacology 20010201

• Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine.

  Journal of clinical psychopharmacology 20010201

• Fully automated on-line determination of olanzapine in serum for routine therapeutic drug monitoring.

  Therapeutic drug monitoring 20010201

• Olanzapine and hypertriglyceridemia.

  Journal of the American Academy of Child and Adolescent Psychiatry 20010201

• A case report of olanzapine-induced hypersensitivity syndrome.

  The American journal of the medical sciences 20010201

• Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010201

• Tolerability and effectiveness of atypical antipsychotics in male geriatric inpatients.

  International journal of geriatric psychiatry 20010201

• Priapism associated with polypharmacy.

  The Journal of clinical psychiatry 20010201

• Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.

  The Journal of clinical psychiatry 20010201

• [Anti-ulcer drug pirenzepin: new use as an aid for prevention of myopia?].

  Klinische Monatsblatter fur Augenheilkunde 20010201

• Treatment of psychogenic polydipsia: comparison of risperidone and olanzapine, and the effects of an adjunctive angiotensin-II receptor blocking drug (irbesartan).

  The Australian and New Zealand journal of psychiatry 20010201

• Interleukin-2 and interleukin-4 increase the survival of retinal ganglion cells in culture.

  Neuroreport 20010122

• [Olanzapine and pregnancy].

  Orvosi hetilap 20010121

• Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT.

  Schizophrenia research 20010115

• A sensitive high-performance liquid chromatographic method using electrochemical detection for the analysis of olanzapine and desmethylolanzapine in plasma of schizophrenic patients using a new solid-phase extraction procedure.

  Journal of chromatography. B, Biomedical sciences and applications 20010105

• Effect of chronic olanzapine treatment on striatal synaptic organization.

  Synapse (New York, N.Y.) 20010101

• Secretion and gene expression of secretory leukocyte protease inhibitor by human airway submucosal glands.

  American journal of physiology. Lung cellular and molecular physiology 20010101

• Lowered seizure threshold on olanzapine.

  The British journal of psychiatry : the journal of mental science 20010101

• Olanzapine: concordant response in monozygotic twins with schizophrenia.

  The British journal of psychiatry : the journal of mental science 20010101

• A novel augmentation strategy for treating resistant major depression.

  The American journal of psychiatry 20010101

• Misdiagnosis of schizophrenia for a patient with epilepsy.

  Psychiatric services (Washington, D.C.) 20010101

• One further case of pancytopenia induced by olanzapine in a Parkinson's disease patient.

  European neurology 20010101

• A predicted cortical serotonergic/cholinergic/GABAergic interface as a site of pathology in schizophrenia.

  Clinical and experimental pharmacology & physiology 20010101

• Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.

  Annual review of medicine 20010101

• Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine.

  Biological psychiatry 20010101

• Consistency of atypical antipsychotic superiority to placebo in recent clinical trials.

  Biological psychiatry 20010101

• Allelic variation in the 5-HT2C receptor (HT2RC) and the increase in slow wave sleep produced by olanzapine.

  Psychopharmacology 20010101

• Mechanisms of acetylcholine-induced vasorelaxation in high K+-stimulated rabbit renal arteries.

  The Journal of veterinary medical science 20010101

• Olanzapine: an updated review of its use in the management of schizophrenia.

  Drugs 20010101

• Bodyweight gain with atypical antipsychotics. A comparative review.

  Drug safety 20010101

• Rapid tranquilization with olanzapine in acute psychosis: a case series.

  The Journal of clinical psychiatry 20010101

• Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.

  The Journal of clinical psychiatry 20010101

• The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms.

  The Journal of clinical psychiatry 20010101

• An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms.

  The Journal of clinical psychiatry 20010101

• Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone.

  The Journal of clinical psychiatry 20010101

• Introduction: a new era in the pharmacotherapy of psychotic disorders.

  The Journal of clinical psychiatry 20010101

• Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychotics.

  The Journal of clinical psychiatry 20010101

• Weight change and atypical antipsychotic treatment in patients with schizophrenia.

  The Journal of clinical psychiatry 20010101

• Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial.

  The Journal of clinical psychiatry 20010101

• Short-term effects of olanzapine in Huntington disease.

  Neuropsychiatry, neuropsychology, and behavioral neurology 20010101

• The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease.

  The Journal of clinical psychiatry 20010101

• Olanzapine may be an effective adjunctive therapy in the management of acne excoriée: a case report.

  Journal of cutaneous medicine and surgery 20010101

• First experiences in combination therapy using olanzapine with SSRIs (citalopram, paroxetine) in delusional depression.

  Neuropsychobiology 20010101

• [Viewpoint of schizophrenic patients: a European survey].

  L'Encephale 20010101

• Reversal of pathologic cardiac parameters after transition from clozapine to olanzapine treatment: a case report.

  Clinical neuropharmacology 20010101

• Pharmacology, distribution and development of muscarinic acetylcholine receptor subtypes in the optic tectum of Rana pipiens.

  Neuroscience 20010101

• A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: functional MRI correlates.

  Neurocase 20010101

• [Obsessive-compulsive disorders in adolescents with diagnosed schizophrenia].

  Psychiatria polska 20010101

• [Subjective and objective evaluation of treating schizophrenia with classic or atypical drugs].

  Psychiatria polska 20010101

• [Incidence of extrapyramidal symptoms during treatment with olanzapine, haloperidol and risperidone: results of an observational study].

  Actas espanolas de psiquiatria 20010101

• [Olanzapine and cognitive-behavioural group therapy in borderline personality disorder].

  Actas espanolas de psiquiatria 20010101

• [Treatment of schizophrenia in subjects with substance use disorders: A review].

  Actas espanolas de psiquiatria 20010101

• Antipsychotic-induced weight gain: a review of the literature.

  The Journal of clinical psychiatry 20010101

• The pharmacology of weight gain with antipsychotics.

  The Journal of clinical psychiatry 20010101

• Priapism after a suicide attempt by ingestion of olanzapine and gabapentin.

  Psychosomatics 20010101

• Hypothesis and hypothesis testing in the clinical trial.

  The Journal of clinical psychiatry 20010101

• Olanzapine: another psychotropic?

  The American journal of hospice & palliative care 20010101

• Diabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literature.

  The Journal of the American Board of Family Practice 20010101

• Treatment with atypical antipsychotics: new indications and new populations.

  Journal of psychiatric research 20010101

• [Olanzapine efficacy in the treatment of cocaine abuse in methadone maintenance patients. Interaction with plasma levels].

  Actas espanolas de psiquiatria 20010101

• Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20010101

• Olanzapine-induced respiratory failure.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20010101

• M1 receptor activation is a requirement for arecoline analgesia.

  Farmaco (Societa chimica italiana : 1989) 20010101

• Olanzapine-lithium encephalopathy.

  Psychosomatics 20010101

• Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence.

  Current opinion in investigational drugs (London, England : 2000) 20010101

• Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats.

  BMC pharmacology 20010101

• New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses--a pilot study.

  European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20010101

• Muscarinic receptor subtypes mediating vasorelaxation of the perforating branch of the human internal mammary artery.

  Pharmacology 20010101

• Hyperglycemia associated with the use of atypical antipsychotics.

  The Journal of clinical psychiatry 20010101

• Review of atypical antipsychotics and weight gain.

  The Journal of clinical psychiatry 20010101

• A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder.

  Journal of child and adolescent psychopharmacology 20010101

• Hyperglycemia and hypertriglyceridemia secondary to olanzapine.

  Journal of child and adolescent psychopharmacology 20010101

• Olanzapine-induced retarded ejaculation: role of paroxetine comedication? A case report.

  Therapie 20010101

• Olanzapine: a review of its use in the treatment of bipolar I disorder.

  CNS drugs 20010101

• Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia.

  Neuroscience 20010101

• Muscarinic receptors influence catecholamine release from the cat carotid body during hypoxia.

  Advances in experimental medicine and biology 20010101

• National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20010101

• Acute, progressive akinetic-rigid syndrome induced by neuroleptics in a case of Wilson's disease.

  The Journal of neuropsychiatry and clinical neurosciences 20010101

• Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia.

  Psychosomatics 20010101

• Persistent psychosis after a single ingestion of 'ecstasy'.

  Psychosomatics 20010101

• Olanzapine usage associated with neuroleptic malignant syndrome.

  Psychosomatics 20010101

• Short report: comparison of patient satisfaction and burden of adverse effects with novel and conventional neuroleptics: a naturalistic study.

  Schizophrenia bulletin 20010101

• [Clinical impact of atypical antipsychotics: prospective 6-month study of inpatients treated with risperidone or olanzapine].

  Therapie 20010101

• Prevention of experimental autoimmune cardiomyopathy in rabbits by receptor blockers.

  Autoimmunity 20010101

• Opposite effects of olanzapine and haloperidol in rat ultrasonic vocalization test.

  Polish journal of pharmacology 20010101

• Cholinergic stimulation of rat acinar cells increases c-fos and c-jun expression via a mitogen-activated protein kinase-dependent pathway.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20010101

• Neuroleptic malignant syndrome due to olanzapine.

  Psychopharmacology bulletin 20010101

• Panic disorder associated with clozapine.

  The American journal of psychiatry 20001201

• Neuroleptic malignant syndrome associated with olanzapine therapy: a case report.

  The Journal of emergency medicine 20001101

• Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs.

  Pharmacopsychiatry 20001101

• Risperidone and tardive dyskinesia: a case of blepharospasm.

  The Australian and New Zealand journal of psychiatry 20001001

• Quetiapine for l-dopa-induced psychosis in PD.

  Neurology 20000926

• Olanzapine and obsessive-compulsive symptoms.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20000901

• Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.

  Archives of general psychiatry 20000901

• A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.

  The Journal of clinical psychiatry 20000901

• The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.

  Clinical therapeutics 20000901

• Esotropia associated with olanzapine.

  Journal of clinical psychopharmacology 20000801

• Case report of withdrawal syndrome after olanzapine discontinuation.

  Journal of clinical psychopharmacology 20000801

• Remission of tardive dyskinesia after changing from flupenthixol to olanzapine.

  European psychiatry : the journal of the Association of European Psychiatrists 20000801

• Olanzapine-induced urinary incontinence: treatment with ephedrine.

  The Journal of clinical psychiatry 20000801

• Olanzapine optimal dose: results of an open-label multicenter study in schizophrenic patients. Olanzapine Late-Phase II Study Group.

  Psychiatry and clinical neurosciences 20000801

• Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine.

  Journal of clinical psychopharmacology 20000601

• Adverse effects of high-dose olanzapine in treatment-refractory schizophrenia.

  Journal of clinical psychopharmacology 20000601

• Differential efficacy of olanzapine for deficit and nondeficit negative symptoms in schizophrenia.

  The American journal of psychiatry 20000601

• Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone.

  The American journal of psychiatry 20000601

• The safety of olanzapine compared with other antipsychotic drugs: results of an observational prospective study in patients with schizophrenia (EFESO Study). Pharmacoepidemiologic Study of Olanzapine in Schizophrenia.

  The Journal of clinical psychiatry 20000501

• Possible neuroleptic malignant syndrome associated with olanzapine.

  The Annals of pharmacotherapy 20000501

• Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con Olanzapina.

  Clinical therapeutics 20000501

• Quetiapine for l-dopa-induced psychosis in PD.

  Neurology 20000411

• Seizures caused by possible interaction between olanzapine and clomipramine.

  Journal of clinical psychopharmacology 20000401

• [A case of mania following olanzapine administration].

  Psychiatria polska 20000101

• [Psychotic syndrome after withdrawal of cyproheptadine: remission with olanzapine].

  Actas espanolas de psiquiatria 20000101

• D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study.

  Journal of psychopharmacology (Oxford, England) 20000101

• Haloperidol-induced impotence improved by switching to olanzapine.

  General hospital psychiatry 20000101

• Hypomania-like syndrome induced by olanzapine.

  International clinical psychopharmacology 19991101

• Worsening of motor features of parkinsonism with olanzapine.

  Movement disorders : official journal of the Movement Disorder Society 19991101

• Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.

  Methods and findings in experimental and clinical pharmacology 19991101

• Olanzapine-induced psychotic mania in bipolar schizo-affective disorder.

  European psychiatry : the journal of the Association of European Psychiatrists 19991101

• Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine.

  Journal of clinical psychopharmacology 19991001

• Olanzapine-induced tardive dystonia.

  The American journal of psychiatry 19991001

• Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine.

  European psychiatry : the journal of the Association of European Psychiatrists 19991001

• Brain SPECT imaging in Huntington's disease before and after therapy with olanzapine. Case report.

  Arquivos de neuro-psiquiatria 19990901

• In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.

  European journal of nuclear medicine 19990801

• Olanzapine-induced mania.

  The American journal of psychiatry 19990701

• Interaction between olanzapine and haloperidol.

  Journal of clinical psychopharmacology 19990601

• [Severe intoxication probably from olanzapine (Zyprexa). Beneficial effect of glucagon].

  Annales francaises d'anesthesie et de reanimation 19990601

• Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group.

  The American journal of psychiatry 19990501

• Olanzapine-induced obsessive-compulsive disorder.

  The American journal of psychiatry 19990501

• In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapine.

  Psychiatry research 19990426

• Risperidone-induced tardive dystonia and psychosis.

  Lancet (London, England) 19990320

• [Neuroleptic malignant syndrome after treatment with olanzapine].

  Ugeskrift for laeger 19990308

• Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine.

  European journal of pharmacology 19990226

• Hyperprolactinemia and male sexual dysfunction.

  The Journal of clinical psychiatry 19990201

• Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.

  Schizophrenia research 19990104

• Olanzapine versus haloperidol treatment in first-episode psychosis.

  The American journal of psychiatry 19990101

• Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.

  European journal of pharmacology 19990101

• Use of olanzapine in hereditary coproporphyria.

  Psychosomatics 19990101

• Olanzapine in the treatment of hallucinosis in idiopathic Parkinson's disease: a cautionary note.

  Journal of neurology, neurosurgery, and psychiatry 19981101

• Mania-like syndrome in a patient with chronic schizophrenia during olanzapine treatment.

  Journal of psychiatry & neuroscience : JPN 19981101

• Alleviation of sulpiride induced tardive akathisia by olanzapine: case report.

  Neurologia (Barcelona, Spain) 19981101

• Olanzapine use in women with antipsychotic-induced hyperprolactinemia.

  The American journal of psychiatry 19981001

• Isoniazid-induced psychosis.

  The Annals of pharmacotherapy 19980901

• Conventional psychotropic-induced tremor extinguished by olanzapine.

  The American journal of psychiatry 19980801

• Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.

  The American journal of psychiatry 19980701

• Acute dystonia with olanzapine.

  The Journal of clinical psychiatry 19980701

• Severe akathisia during olanzapine treatment of acute schizophrenia.

  Pharmacopsychiatry 19980701

• Worsening of obsessive-compulsive symptoms following treatment with olanzapine.

  The American journal of psychiatry 19980601

• Olanzapine-induced manic-like syndrome.

  The Journal of clinical psychiatry 19980601

• Mania associated with olanzapine.

  Journal of the American Academy of Child and Adolescent Psychiatry 19980201

• The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine.

  Psychopharmacology bulletin 19980101

• Priapism following olanzapine administration in a patient with multiple sclerosis.

  Psychosomatics 19980101

• Adverse effects of the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.

  The Journal of clinical psychiatry 19980101

• Olanzapine attenuates the reinforcing effects of cocaine.

  European journal of pharmacology 19971204

• High-dose olanzapine for treatment-refractory schizophrenia.

  The American journal of psychiatry 19971101

• Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.

  The Journal of clinical psychiatry 19971101

• Propranolol treatment of olanzapine-induced akathisia.

  The American journal of psychiatry 19970901

• Similarities and differences between the subchronic and withdrawal effects of clozapine and olanzapine on forelimb force steadiness.

  Psychopharmacology 19970801

• The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations.

  Schizophrenia research 19970725

• Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia.

  The Journal of clinical psychiatry 19970501

• Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.

  The American journal of psychiatry 19970401

• Clozapine inhibits catalepsy induced by olanzapine and loxapine, but prolongs catalepsy induced by SCH 23390 in rats.

  Naunyn-Schmiedeberg's archives of pharmacology 19970301

• Characterisation of [3H]-darifenacin as a novel radioligand for the study of muscarinic M3 receptors.

  Journal of receptor and signal transduction research 19970101

• Safety of olanzapine.

  The Journal of clinical psychiatry 19970101

• Dosing the antipsychotic medication olanzapine.

  The Journal of clinical psychiatry 19970101

• Effects of a cardioselective M2 receptor antagonist, AF-DX 116, on ventricular arrhythmias in dogs.

  Heart and vessels 19970101

• Muscarinic antagonists microinjected into the subthalamic nucleus decrease muscular rigidity in reserpinized rats.

  Neuroscience letters 19960809

• Binding of the labelled muscarinic toxin 125I-MT1 to rat brain muscarinic M1 receptors.

  European journal of pharmacology 19960603

• A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors.

  FEBS letters 19940919

• Activation of pirenzepine-sensitive muscarinic receptors induces a specific pattern of immediate-early gene expression in rat brain neurons.

  Brain research. Molecular brain research 19940701

• Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes.

  British journal of pharmacology 19940601

• Assessment of the muscarinic receptor subtypes involved in pilocarpine-induced seizures in mice.

  Neuroscience letters 19940227

• Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.

  The Journal of pharmacology and experimental therapeutics 19921101

• AF102B, a muscarinic M1 receptor agonist, mimics some effects of acetylcholine on neurons of rat hippocampus slices.

  European journal of pharmacology 19920910

• Limbic thalamus in rabbit: architecture, projections to cingulate cortex and distribution of muscarinic acetylcholine, GABAA, and opioid receptors.

  The Journal of comparative neurology 19920508

• Binding of [3H]AF-DX 384 to cloned and native muscarinic receptors.

  The Journal of pharmacology and experimental therapeutics 19911101

• Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.

  British journal of pharmacology 19910101

• Laminar distributions of muscarinic acetylcholine, serotonin, GABA and opioid receptors in human posterior cingulate cortex.

  Neuroscience 19900101

• The existence of stable enantiomers of telenzepine and their stereoselective interaction with muscarinic receptor subtypes.

  Molecular pharmacology 19890401

• Possible mechanisms of anti-cholinergic drug-induced bradycardia.

  European journal of clinical pharmacology 19880101

• Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine.

  British journal of pharmacology 19860901

• Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist.

  Life sciences 19860505

• The relative selectivity of anticholinergic drugs for the M1 and M2 muscarinic receptor subtypes.

  Movement disorders : official journal of the Movement Disorder Society 19860101

• Gastric cytoprotection by pirenzepine in rats: evaluating method for cytoprotective activity by antisecretory agents.

  Japanese journal of pharmacology 19850801

• [3H]Pirenzepine identifies putative M1 muscarinic receptors in human stellate ganglia.

  Brain research 19840102